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Abstract 16 
Exposure to hypoxia appears to depress appetite and energy intake, however the mechanisms 17 
are not fully understood. The aim of this review was to determine the magnitude of changes in 18 
hunger and energy intake in hypoxic compared with normoxic environments, and establish any 19 
alterations in appetite-related hormone concentrations. PubMed and The Cochrane Library as 20 
well as MEDLINE, SPORTDiscus, PsycINFO and CINAHL, via EBSCOhost, were searched 21 
through 1st April 2017 for studies that evaluated hunger, energy intake and/or appetite-related 22 
hormones in normoxia and during hypoxic exposure in a within-measures design. A total of 28 23 
studies (comprising 54 fasted and 22 postprandial comparisons) were included. A random-24 
effects meta-analysis was performed to establish standardised mean difference (SMD) with 25 
95% confidence intervals. Hypoxic exposure resulted in a trivial but significant decrease in 26 
postprandial hunger scores (SMD: -0.15, 95% CI: -0.29 to -0.01; n=14; p=0.043) and a 27 
moderate decrease in energy intake (SMD: -0.50, 95% CI: -0.85 to -0.15; n=8; p=0.006). 28 
Hypoxic exposure resulted in a decrease (albeit trivial) in postprandial acylated ghrelin 29 
concentrations (SMD: -0.16, 95% CI: -0.25 to -0.08; n=7; p<0.0005), and a moderate increase 30 
in fasted insulin concentrations (SMD: 0.41, 95% CI: 0.17 to 0.65; n=34; p=0.001). Meta-31 
regression revealed a decrease in postprandial acylated ghrelin concentrations (p=0.010) and 32 
an increase in fasted insulin concentrations (p=0.020) as hypoxic severity increased. Hypoxic 33 
exposure reduces hunger and energy intake, which may be mediated by decreased circulating 34 
concentrations of acylated ghrelin and elevated insulin concentrations. PROSPERO 35 
registration number: CRD42015017231.  36 
 37 
  38 
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Introduction 39 
Chronic exposure to hypoxia is associated with a decrease in body mass (Pulfrey & Jones, 40 
1996; Rose et al., 1988; Sergi et al., 2010; Zaccagni et al., 2014), with as much as 67% of body 41 
mass losses coming from reductions in fat-free mass (Rose et al., 1988). Such losses of lean 42 
mass at altitude are likely to have deleterious consequences for altitude sojourners by impairing 43 
physical capabilities (Sergi et al., 2010) and suppressing immune function (Mazzeo, 2005). 44 
These changes in body mass and composition appear to be the result of a chronic negative 45 
energy balance due to reductions in appetite and ad-libitum energy intake (Aeberli et al., 2013; 46 
Matu et al., 2017a; Wasse et al., 2012), in combination with potential increases in resting 47 
energy expenditure (Butterfield et al., 1992; Matu et al., 2017a), compared with sea level. 48 
Developing a better understanding of the changes in appetite and energy intake that occur 49 
during hypoxic exposure is vital in designing interventions to minimise energy deficits.  50 
Despite a substantial amount of recent research (Debevec, 2017), the mechanisms 51 
underlying reductions in appetite during hypoxic exposure are not well understood. 52 
Historically, studies have attributed the loss of appetite to acute mountain sickness (AMS), 53 
however this is unlikely to be the sole cause, as symptoms of anorexia persist when AMS has 54 
subsided (Tschop & Morrison, 2001), and others have found appetite suppression in individuals 55 
without symptoms of AMS (Matu et al., 2017a). Appetite is regulated, in part, by the 56 
neuroendocrine system (Murphy & Bloom, 2006), and multiple hormones have been 57 
implicated as mediators of hunger and satiety in hypoxia (Bailey et al., 2015; Debevec et al., 58 
2014a; Debevec et al., 2016; Matu et al., 2017a; Sierra-Johnson et al., 2008; Shulka et al., 2005; 59 
Tschop et al., 1998). Acylated ghrelin has been hypothesized to act physiologically to signal 60 
hunger and initiate eating, and has received growing attention in hypoxic research during recent 61 
years (Bailey et al., 2015; Matu et al., 2017a; Morishima & Goto, 2016; Wasse et al., 2012). 62 
Current evidence suggests that appetite and acylated ghrelin are concomitantly suppressed 63 
during exposure to high, but not moderate, simulated altitude, which suggests a potential 64 
mediating role of this hormone in altitude-induced anorexia (Matu et al., 2017a). However, due 65 
to the complex chemical preparation required for accurate acylated ghrelin measurements 66 
(Hosoda et al., 2004), total ghrelin concentrations have been more commonly measured in 67 
response to hypoxic exposure and the findings remain equivocal (Benso et al., 2007; Debevec 68 
et al., 2014a; Debevec et al., 2016; Mekjavic et al., 2016; Riedl et al., 2012; Riepl et al., 2012; 69 
Shulka et al., 2005).  70 
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The role of circulating leptin concentrations as a mediator of appetite and energy intake 71 
changes at altitude has been a topic of great interest and controversy. Leptin is an adipocytokine 72 
that has been proposed to expresses regulatory physiological effects on appetite and 73 
metabolism (Klok et al., 2007). It is well known that exposure to altitude stimulates hypoxia-74 
inducible factor 1 (HIF-1) (Semenza, 2012). HIF-1 can transactivate the human leptin gene 75 
promoter, potentially increasing circulating leptin concentrations (Grosfeld et al., 2002). On 76 
the contrary, altitude exposure is often associated with a significant loss of adiposity due to 77 
increased energy expenditure and/or decreased energy intake (Rose et al., 1988; Zaccagni et 78 
al., 2014). This would therefore reduce leptin expression in adipose tissue. Consequently, the 79 
effects of hypoxic exposure on leptin concentrations remain ambiguous (Sierra-Johnson et al., 80 
2008), and several confounding factors may regulate leptin concentrations in hypoxia, such as 81 
the completion of varying amounts of physical activity (Yu et al., 2017), as well as the duration 82 
and severity of hypoxic exposure. Other hormones which have been investigated in relation to 83 
appetite suppression during hypoxic exposure include glucagon-like peptide-1 (GLP-1) (Bailey 84 
et al., 2004; Bailey et al., 2015; Debevec et al., 2014a; Debevec et al., 2016; Matu et al., 2017a; 85 
Mekjavic et al., 2016; Morishima & Goto, 2016; Snyder et al., 2008), pancreatic polypeptide 86 
(PP) (Matu et al., 2017a; Riepl et al., 2012), peptide YY (PYY) (Bailey et al., 2015; Debevec 87 
et al., 2014a; Debevec et al., 2016; Mekjavic et al., 2016;  Wasse et al., 2012), cholecystokinin 88 
(CCK) (Aeberli et al., 2013; Riepl et al., 2012) and insulin (Debevec et al., 2014a; Matu et al., 89 
2017a; Mekjavic et al., 2016). The results of these studies are equivocal, possibly due to a wide 90 
variety of methodologies employed.  91 
 A clear understanding of the dose-response and underlying regulation of hypoxia-92 
induced appetite suppression in humans requires the equivocal results of previous studies to be 93 
explained. In an attempt to resolve these discrepancies, our objective was to conduct a 94 
systematic review and meta-analysis of within-measures studies which have investigated the 95 
effect of hypoxia on hunger, energy intake and/or hormone concentrations implicated in 96 
appetite regulation. Using post-hoc subgroup analyses and meta-regression, we also aimed to 97 
identify any study characteristics which could help to explain the observed results.  98 
 99 
Methods 100 
This systematic review and meta-analysis was performed in accordance with the PRISMA 101 
(Preferred Reporting Items for Systematic Review and Meta-analyses) guidelines (Liberati et 102 
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al., 2009) and was prospectively registered with the PROSPERO database 103 
(CRD42015017231).  104 
 105 
Literature Search 106 
PubMed and The Cochrane Library as well as MEDLINE, SPORTDiscus, PsycINFO and 107 
CINAHL, via EBSCOhost, were searched from 3rd March 2015 through 1st April 2017. 108 
Keyword searchers were performed for: ‘altitude’, ‘hypoxia’, ‘hypoxic’, ‘mountaineering’, 109 
‘appetite’, ‘appetite hormones’, ‘ghrelin’, ‘acylated ghrelin’, ‘glp-1’, ‘glucagon like peptide-110 
1’, ‘peptide YY’, ‘PYY’, ‘leptin’, ‘pancreatic polypeptide’, ‘insulin’, ‘hunger’, ‘satiety’, 111 
‘energy intake’, ‘food intake’, ‘energy balance’ (details of the search strategy are outlined in 112 
the Supplementary Material). This gave a total of 68 combinations. Reference lists of eligible 113 
studies and review articles were also searched. If only the abstract or partial data were published 114 
then the author was contacted for the full data set. No language or date of publication 115 
restrictions were applied during the searches.  116 
 117 
Inclusion Criteria 118 
For inclusion, studies were required to meet the following criteria: participants in the studies 119 
were between 18 and 65 years old, non-smokers, not pregnant and had no history of diabetes, 120 
gastrointestinal, inflammatory, metabolic, cardiovascular, neurological or psychological 121 
disease(s). Studies were included if they were published in peer-review journals or were 122 
available as published conference proceedings, theses or dissertations, to minimise the effect 123 
of any potential publication bias.  124 
All studies were required to contain at least one of the following measures: subjective 125 
hunger perceptions measured via visual analogue scales; measurements of blood acylated 126 
ghrelin, total ghrelin, leptin, GLP-1, PYY and/or insulin concentrations; and/or energy intake 127 
measured by the researcher as the weight of food or kJ/kcal (i.e. not self-reported). Hunger was 128 
used as opposed to other subjective appetite measures, as hunger is the most commonly utilised 129 
scale and therefore allowed for the inclusion of more studies. 130 
All studies were required to contain the required measure(s) during a hypoxic exposure. 131 
Hypoxic exposure interventions were defined as original investigations including exposure to 132 
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a true altitude via geographical location (e.g. mountaineering) or a simulated normobaric or 133 
hypobaric exposure (e.g. hypoxic chamber, hypoxic tent or breathing mask). Exposures were 134 
required to be ≥1000m in altitude (or a simulated hypoxic equivalent) and be of ≥ 30 minutes 135 
in duration. Studies were also required to contain an appropriate within-subjects control, i.e. 136 
the equivalent measure(s) in normoxic conditions prior to the hypoxic exposure or a separate 137 
control (normoxic) condition.  138 
Two researchers (JM and KD) independently assessed studies for inclusion and later 139 
compared notes to reach a mutual consensus. Disagreements about the eligibility of any 140 
particular studies were resolved by a third reviewer (TI). Potential studies that could be 141 
included based on their title or abstract were retrieved in full-text and reviewed against the 142 
inclusion/exclusion criteria independently by two researchers (JM and KD) with a third 143 
researcher (TI) used to settle any disputes. In total, 28 studies met the inclusion criteria and 144 
were included in this meta-analysis (supplementary figure 1). For a variable to be included in 145 
the meta-analysis a minimum of three studies, measuring the respective variable, were required 146 
to meet the inclusion criteria.  147 
 148 
Data abstraction 149 
Data were extracted independently by two researchers (JM and KD) into a standardised 150 
spreadsheet, which included (i) characteristics of articles valid for review; (ii) the Cochrane 151 
Collaboration’s tool for assessing risk of bias and (iii) outcome data suitable for successive 152 
analysis based on mean, SD and sample size. Additional data were collected for study design, 153 
participant characteristics, severity and duration of hypoxic exposure, acclimatisation status 154 
and activity status of participants. Participants were deemed to be passive if no exercise was 155 
conducted during the hypoxic exposure (e.g. bedrest, or ascent to altitude by vehicle). 156 
Participants were deemed to be active if exercise was conducted during the hypoxic exposure 157 
(e.g. exercise capacity tests, or trekking to altitude). When studies employed multiple measures 158 
of the same variable in the same hypoxic severity then the first measure and chronologically 159 
final measure were used for analysis. This ensured that single studies were not weighted too 160 
highly due to multiple measures whilst still accounting for the effect of acute and chronic 161 
hypoxic exposure. 162 
Where blood analyte values were reported in pmolL-1, values were converted to pgmL-163 
1 as follows: multiplied by 4 for total PYY, 3.297 for total GLP-1, 3.37 for acylated and total 164 
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ghrelin, and 16 for leptin. Insulin was converted from pmolL-1 to µU.mL-1.where necessary by 165 
dividing by six. Where values were only presented in figure form, the figure was digitized 166 
using graph digitizer software (DigitizeIt, Germany) and the means and SD/SEM were 167 
measured manually at the pixel level to the scale provided on the figure. If area under the curve 168 
values were reported rather than mean values, the authors of the relevant studies were contacted 169 
to obtain the raw dataset and mean values were subsequently calculated. 170 
 171 
Assessment of risk of bias in included studies 172 
To assess the risk of bias in included studies The Cochrane Collaboration’s tool for assessing 173 
risk of bias (Higgins et al., 2011) was used independently by two reviewers (JM and LD). Each 174 
study was assessed in the following six domains: sequence generation, allocation concealment, 175 
blinding of participants, personnel and outcome assessors, incomplete outcome data, selective 176 
outcome reporting, and other sources of bias (e.g. has been claimed to have been fraudulent). 177 
A judgement was made on each of the domains by the two independent researchers as to 178 
whether they were ‘high risk ‘or ‘low risk’. When insufficient detail was reported then the 179 
judgement of ‘unclear risk’ was made. Disagreements were solved initially via discussion 180 
between the two independent reviewers however a third reviewer (TI) was consulted for dispute 181 
resolution. ‘Risk of bias graphs’ were computed in Review Manager (RevMan) 5.3 (The 182 
Cochrane Collaboration) to include low, unclear and high risk for each domain.  183 
 184 
Statistical analysis 185 
Missing standard deviations were calculated from standard errors or confidence intervals. 186 
Outcome measures were converted into the standardised mean difference (SMD) with 95% 187 
confidence intervals (CI) and were used as the summary statistic. The SMD represents the size 188 
of the effect of the intervention relative to the variability observed in that intervention. A 189 
random-effects meta-analysis was performed by JM, JG and KD using Comprehensive Meta-190 
Analysis Software (version 3, Biostat, Englewood, NJ, USA). A random-effects model was 191 
chosen over a fixed effects model due to unexplained heterogeneity in the included studies 192 
(Ades et al., 2005). The inputted data included sample sizes, outcome measures with their 193 
respective standard deviations, and a correlation coefficient for within-subject measurements. 194 
These correlation coefficients were estimated from prior studies in our laboratory and other 195 
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published studies, and were as follows: fasted hunger r = 0.52, postprandial hunger r = 0.61, 196 
energy intake r = 0.51, postprandial acylated ghrelin r = 0.97, fasted total ghrelin r = 0.40, 197 
postprandial total ghrelin r = 0.53, fasted leptin r = 0.32, fasted GLP-1 r = 0.94, postprandial 198 
GLP-1 r = 0.95, fasted PYY r = 0.70, postprandial PYY r = 0.86, fasted insulin r = 0.43 and 199 
postprandial insulin r = 0.53. 200 
We interpreted SMD values of <0.20 as trivial, 0.20-0.39 as small, 0.40-0.80 as 201 
moderate and >0.80 as large (Cohen, 1969). A negative SMD indicates that hypoxic exposure 202 
was associated with a decrease in the respective outcome variable while a positive SMD 203 
indicates that hypoxic exposure was associated with an increase in the respective outcome 204 
variable. Heterogeneity between trials was assessed using the I-squared statistic, where 0-40% 205 
suggests heterogeneity might not be important, 30-60% may represent moderate heterogeneity, 206 
50-90% may represent substantial heterogeneity and 75-100% represents substantial 207 
heterogeneity (Higgins & Thompson, 2002). This measure of heterogeneity was complimented 208 
by also reporting the Tau-squared statistic and the Chi-squared statistic. To examine whether 209 
any conclusions were dependent on a single study, sensitivity analyses was employed for each 210 
variable by repeating the analyses with each study omitted in turn. 211 
Where significant effects of hypoxic exposure were observed, post-hoc meta-regression 212 
analysis (method-of-moments model) was performed. This analysis was used to determine 213 
whether continuous data, including duration or severity of hypoxic exposure, could explain the 214 
variation in the SMD values observed between studies for a respective outcome measure. 215 
Where data were available, subgroup meta-analysis was performed for categorical variables 216 
including acclimatisation status, method of achieving hypoxic exposure and physical activity 217 
status.  218 
 219 
Exploration of small study effects 220 
Small study effects were explored with funnel plots of standard difference in means versus 221 
standard errors (Sterne et al., 2011) and by quantifying Egger’s linear regression intercept. A 222 
large and statistically significant Egger statistic indicates the presence of a small study effect. 223 
 224 
Results 225 
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Overview 226 
Supplementary figure 1 outlines the flowchart of study selection. In total, 28 studies met the 227 
inclusion criteria for the meta-analysis. All included studies had been published (or accepted 228 
for publication) in peer-reviewed scientific journals at the time of inclusion. Within the 28 229 
included studies a total of 54 fasted and 22 postprandial comparisons were included between 230 
normoxic and hypoxic conditions. Comparisons were segregated into fasted (see 231 
supplementary table 1) and postprandial (see supplementary table 2) responses to differentiate 232 
between findings during these two distinct periods of appetite regulation. Fasted comparisons 233 
represent comparisons of single time points obtained after an overnight fast. Eleven out of the 234 
12 studies which reported postprandial comparisons provided standardised meals to 235 
participants with an energy content of 1347 - 3205 kJ (mean: 2128 kJ) and an observation 236 
period of 50 – 420 minutes (mean: 210 minutes). The remaining study which assessed 237 
postprandial comparisons measured hunger responses to ad libitum feeding during the waking 238 
hours of an entire day (Westerterp-Platenga et al., 1999). All studies involving postprandial 239 
comparisons provided mixed macronutrient meals, with seven studies providing this in the 240 
form of solid foods and five studies providing this in a liquid form. Visual inspection of the 241 
data suggests that the composition of meals provided and observation periods employed did 242 
not dictate the outcomes of postprandial variables. 243 
 244 
Participant demographics and hypoxic exposure characteristics 245 
A total of 407 participants (351 men and 56 women; 86% men) were included in this meta-246 
analysis. Mean age was reported in 22 out of the 28 studies and ranged from 21 to 44 years 247 
(mean: 29 years). Mean BMI was reported in 18 out of the 28 studies and ranged from 20.7 to 248 
25.0 kg·m-2 (mean: 23.4 kg·m-2). For all comparisons hypoxic severity ranged from 2134 to 249 
7753m (mean: 4302m) and duration of hypoxic exposure ranged from 50 minutes to two 250 
months (mean: 10 days).  251 
 252 
Meta-Analysis 253 
Individual study statistics and results for each outcome variable are summarised in 254 
supplementary tables 3 - 15.   255 
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 256 
Standardised mean difference and moderator variables for hunger scores 257 
Hypoxic exposure resulted in a small decrease in fasted hunger scores (SMD: -0.35, 95% CI: -258 
0.76 to 0.07; n = 15; p = 0.102). The degree of heterogeneity may be substantial between these 259 
studies (I2 = 81.6%; Q = 76.0, τ2 = 0.521, df = 14). Sensitivity analysis revealed that the removal 260 
of one comparison (Aeberli et al. 2013-2) further decreased the SMD to -0.43 (95% CI: -0.85 261 
to -0.01; p = 0.045). Inspection of the funnel plot and Egger’s regression intercept revealed that 262 
there was evidence of small study effects (intercept = -5.522, 95% CI: -9.25 to -1.79; p = 0.007).  263 
Hypoxic exposure resulted in a trivial decrease in postprandial hunger scores (SMD: -264 
0.15, 95% CI: -0.29 to -0.01; n = 14; p = 0.043; Figure 1). The degree of heterogeneity was 265 
found to be low between these studies (I2 = 5.2%; Q = 13.7, τ2 = 0.004 and df = 13). Sensitivity 266 
analysis revealed that the removal of eight single comparisons in turn moderated the statistical 267 
interpretation of the results; for example the removal of the comparison with the largest 268 
negative SMD (Wasse et al., 2012) would increase the SMD to -0.11 (95% CI: -0.25 to 0.03; 269 
p = 0.118). Subgroup analysis indicated a difference between active and passive participants 270 
(p = 0.049), with postprandial hunger being suppressed to a greater extent in passive 271 
participants (Table 1). Utilising a meta-regression model, neither hypoxic severity nor duration 272 
of exposure were associated with postprandial hunger scores. Inspection of the funnel plot and 273 
Egger’s regression intercept revealed that there was evidence of small study effects (intercept 274 
= -3.332, 95% CI: -6.06 to -0.60; p = 0.021).  275 
[Insert Figure 1 near here] 276 
 277 
Standardised mean difference and moderator variables for energy intake  278 
Hypoxic exposure resulted in a moderate decrease in energy intake (SMD: -0.50, 95% CI: -279 
0.85 to -0.15; n = 8; p = 0.006; Figure 2). The degree of heterogeneity may be substantial 280 
between these studies (I2 = 64.5%; Q = 19.7, τ2 = 0.159 and df = 7). Sensitivity analysis revealed 281 
minor changes only, and these changes did not substantially alter the overall mean effect. Using 282 
duration of exposure as a moderator in a meta-regression model, a shorter duration of exposure 283 
tended to be associated with a larger decrease in energy intake. The slope of the regression 284 
tended to be positive (p = 0.056; Table 1), with a standardised increase in energy intake of 285 
0.051 units for every one day of hypoxic exposure. Inspection of the funnel plot and Egger’s 286 
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regression intercept revealed that there was little evidence of small study effects (intercept = -287 
4.065, 95% CI: -10.04 to 1.91; p = 0.147).  288 
[Insert Figure 2 near here] 289 
 290 
Standardised mean difference and moderator variables for acylated ghrelin concentrations 291 
Hypoxic exposure resulted in a trivial decrease in postprandial acylated ghrelin concentrations 292 
(SMD: -0.16, 95% CI: -0.25 to -0.08; n = 7; P < 0.0005; Figure 3). The degree of heterogeneity 293 
was found to be moderate between these studies (I2 = 56.7%; Q = 13.9, τ2 = 0.007 and df = 6). 294 
Sensitivity analysis revealed minor changes only, and these changes did not substantially 295 
impact the overall mean effect. Using hypoxic severity as a moderator in a meta-regression 296 
model, a higher degree of hypoxia was associated with a larger decrease in acylated ghrelin 297 
concentrations (Figure 4). The slope of the regression was negative (slope: -0.0001, 95% CI -298 
0.0002 to -0.0000; p = 0.010; Table 1), with a standardised decrease in acylated ghrelin of 0.1 299 
units for every 1000m increase in hypoxic severity. Inspection of the funnel plot and Egger’s 300 
regression intercept revealed that there was little evidence of small study effects (intercept = -301 
5.431, 95% CI: -21.82 to 10.96; p = 0.467).  302 
[Insert Figure 3 and 4 near here] 303 
 304 
Standardised mean difference and moderator variables for total ghrelin concentrations 305 
Hypoxic exposure resulted in trivial changes in fasted (SMD: 0.00, 95% CI: -0.33 to 0.34; n = 306 
14; p = 0.987) and postprandial (SMD: 0.02, 95% CI: -0.37 to 0.41; n = 5; p = 0.920) total 307 
ghrelin concentrations. The degree of heterogeneity may be substantial for fasted comparisons 308 
(I2 = 74.7%; Q = 51.3, τ2 = 0.284 and df = 13) and low for postprandial comparisons (I2 = 309 
33.4%; Q = 6.0, τ2 = 0.064 and df = 4). Sensitivity analysis revealed only minor changes in the 310 
SMDs for both fasted and postprandial total ghrelin concentrations. Inspection of the funnel 311 
plot and Egger’s regression intercept revealed that there was little evidence of small study 312 
effects for both fasted (1.104, 95% CI: -2.82 to 5.03; p = 0.552) and postprandial (-3.503, 95% 313 
CI: -10.62 to 3.61; p = 0.215) total ghrelin concentrations.  314 
 315 
Standardised mean difference and moderator variables for GLP-1 concentrations 316 
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Hypoxic exposure resulted in a trivial increase in fasted (SMD: 0.03, 95% CI: -0.11 to 0.17; n 317 
= 8; p = 0.684) and postprandial (SMD: 0.03, 95% CI: -0.05 to 0.11; n = 10; p = 0.474) GLP-318 
1 concentrations. The degree of heterogeneity may be substantial for fasted comparisons (I2 = 319 
62.1%; Q = 18.5, τ2 = 0.024 and df = 7) and was moderate for postprandial comparisons (I2 = 320 
39.2%; Q = 14.8, τ2 = 0.006 and df = 9). Sensitivity analysis revealed only minor changes in 321 
the SMDs for both fasted and postprandial GLP-1 concentrations. Inspection of the funnel plot 322 
and Egger’s regression intercept revealed that there was little evidence of small study effects 323 
for both fasted (intercept = 5.819, 95% CI: -4.71 to 16.35; p = 0.225) and postprandial (intercept 324 
= 4.524, 95% CI: -3.73 to 12.78; p = 0.242) GLP-1 concentrations.  325 
 326 
Standardised mean difference and moderator variables for leptin concentrations  327 
Hypoxic exposure resulted in a trivial decrease in fasted leptin concentrations (SMD: -0.09, 328 
95% CI: -0.40 to 0.23; n = 25; p = 0.588). The degree of heterogeneity was found to be 329 
substantial between these studies (studies (I2 = 82.8%; Q = 139.8, τ2 = 0.493 and df = 24). 330 
Sensitivity analysis revealed minor changes only, and these changes did not impact the overall 331 
mean effect. Inspection of the funnel plot and Egger’s regression intercept revealed that there 332 
was little evidence of small study effects (intercept = 0.953, 95% CI: -1.97 to 3.87; p = 0.506).  333 
 334 
Standardised mean difference and moderator variables for PYY concentrations 335 
Hypoxic exposure resulted in a trivial increase in fasted (SMD: 0.02, 95% CI: -0.18 to 0.21; n 336 
= 7; p = 0.865) and postprandial (SMD: 0.02, 95% CI: -0.14 to 0.18; n = 8; p = 0.810) PYY 337 
concentrations. The degree of heterogeneity was low for fasted comparisons (I2 = 0.0%; Q = 338 
3.2, τ2 = 0.000 and df = 6) and moderate for postprandial comparisons (I2 = 44.2%; Q = 12.6, 339 
τ2 = 0.023 and df = 7). Sensitivity analysis revealed only minor changes in the SMDs for both 340 
fasted and postprandial PYY concentrations. Inspection of the funnel plot and Egger’s 341 
regression intercept revealed that there was some evidence of small study effects for fasted 342 
PYY concentrations (-9.938, 95% CI: -7.87 to 0.00; p = 0.050) but little evidence for 343 
postprandial PYY concentrations (-2.485, 95% CI: -14.86 to 9.89; p = 0.641).  344 
 345 
Standardised mean difference and moderator variables for insulin concentrations 346 
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Hypoxic exposure resulted in a moderate increase in fasted insulin concentrations (SMD: 0.41, 347 
95% CI: 0.17 to 0.65; n = 34; p = 0.001; Figure 4). The degree of heterogeneity may be 348 
substantial between these studies (I2 = 70.6%; Q = 112.1, τ2 = 0.323, df = 33). Sensitivity 349 
analysis revealed minor changes only, and these changes did not impact the overall mean effect. 350 
Subgroup analysis indicated a difference between the acclimatisation status of the participants 351 
(p < 0.0005), with acclimatised individuals experiencing a larger increase in insulin 352 
concentrations. Additionally, there was a difference between the methods of achieving hypoxia 353 
(p < 0.0005), with simulated hypobaric hypoxia inducing the largest increases in insulin 354 
concentrations (Table 1). Using hypoxic severity as a moderator in a meta-regression model, a 355 
higher degree of hypoxia was associated with a greater increase in insulin concentration (Figure 356 
6). The slope of the regression was positive (slope: 0.0003, 95% CI 0.0000 to 0.0005; p = 357 
0.020; Table 1), with a standardised increase in insulin of 0.3 units for every 1000m increase 358 
in hypoxic severity. Inspection of the funnel plot and Egger’s regression intercept revealed that 359 
there was evidence of small study effects (intercept = 2.617, 95% CI: 0.78 to 4.46; p = 0.007).  360 
Hypoxic exposure resulted in a small decrease in postprandial insulin concentrations 361 
(SMD: -0.035, 95% CI: -0.22 to 0.15; n = 11; p = 0.707). The degree of heterogeneity was 362 
found to be low between these studies (I2  0.00%; Q = 9.5, τ2  0.00 and df = 10). Sensitivity 363 
analysis revealed minor changes only, and these changes did not impact the overall mean effect. 364 
Inspection of the funnel plot and Egger’s regression intercept revealed that there was evidence 365 
of small study effects (intercept = -5.36, 95% CI: -9.03 to -1.69; p = 0.009).  366 
[Insert Figure 5 and 6 near here] 367 
[Insert Table 1 near here] 368 
 369 
Risk of bias 370 
Since many of the studies included were high altitude expeditions, certain biases were often 371 
unavoidable, such as blinding of participants and personnel (Figure 7).  372 
[Insert Figure 7 near here] 373 
 374 
Discussion 375 
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The purpose of this meta-analysis was to examine the effect of hypoxic exposure on hunger 376 
and energy intake responses, and to investigate changes in appetite-related hormones as 377 
potential mechanistic variables. We observed decreases in postprandial hunger scores and 378 
energy intake during hypoxic exposure compared with normoxia. Furthermore, we found 379 
postprandial acylated ghrelin concentrations to be suppressed and fasted insulin concentrations 380 
to be elevated during hypoxic exposure compared with normoxia. The observed reductions in 381 
postprandial hunger and energy intake accord with the hypothesised orexigenic effects of 382 
acylated ghrelin (Monteiro & Batterham, 2017) and anorexigenic effects of insulin (Air et al., 383 
2002; Hallschmid et al., 2012). We did not find any significant effects of hypoxic exposure, 384 
compared with normoxia, on circulating total ghrelin, GLP-1, leptin or PYY concentrations, 385 
which suggests that these hormones are unlikely to play a role in altitude-induced anorexia. 386 
 Interestingly, the reductions observed in postprandial hunger during hypoxia compared 387 
with normoxia do not appear to be moderated by the duration of hypoxic exposure. This 388 
speculation aligns with previous research that has observed significant reductions in appetite 389 
with both acute (Matu et al., 2017a; Wasse et al., 2012) and chronic (Westerterp et al., 1994; 390 
Westerterp-Platenga et al., 1999) hypoxic exposures. However, reductions in energy intake 391 
tended to be associated with a shorter duration of hypoxic exposure, signifying a possible 392 
acclimatisation response during prolonged exposures. No other variables were found to be 393 
moderated by the duration of hypoxic exposure, therefore suggesting that other factors may be 394 
involved in the regulation of energy intake at altitude. Surprisingly, subgroup analysis revealed 395 
that hypoxic exposure was associated with a smaller reduction in postprandial hunger in the 396 
studies involving the completion of physical activity than those involving passive exposure to 397 
hypoxia. This finding may seem unexpected considering the longstanding evidence that 398 
strenuous exercise (≥60% of maximum oxygen uptake) induces a transient suppression of 399 
appetite known as exercise-induced anorexia (Deighton & Stensel, 2014). Although it is 400 
difficult to provide a precise explanation for this observation, it seems feasible that any 401 
exercise-induced appetite suppression during normoxic trials may have reduced the relative 402 
decrease in hunger during matched hypoxic trials due to a baseline effect. It must also be 403 
acknowledged that subgroup and meta-regression analyses are observational, in contrast to the 404 
main analysis and summary effect which represent the impact of the hypoxic interventions. 405 
Subsequently, it is feasible that the moderating effect of activity status on postprandial hunger 406 
is confounded by other factors within the study designs such as the participant characteristics 407 
or the nature of the hypoxic exposure (type, duration, severity of hypoxia etc.).  408 
15 
 
It must be noted that appetite perceptions and hormonal regulation are just two aspects 409 
of a multifaceted system controlling energy intake in humans. Hypoxia has been shown to 410 
degrade the taste of food in both humans (Matu et al., 2017b) and rodents (Ettinger & Staddon, 411 
1982), and this could potentially alter food reward (Berthoud, 2006). Furthermore, individuals 412 
exposed to chronic altitude may consciously attempt to maintain energy balance to avoid illness 413 
and fatigue (Matu et al., 2017b). This behavioural regulation of energy intake may confound 414 
the observed reductions in energy intake during chronic hypoxic exposure. It is also possible 415 
that the initial body composition and fitness levels of the participants included in the current 416 
review may alter their hormonal responses to altitude. For example, an increased adiposity can 417 
lead to a decrease in insulin and leptin sensitivity (Adam et al., 2009). However, not enough 418 
studies reported these data for them to be included as moderator variables.  419 
 The current review found an inverse association between hypoxic severity and changes 420 
in acylated ghrelin concentrations. This finding concords with those of Matu et al. (2017a), 421 
who found that acylated ghrelin was suppressed with high but not moderate simulated altitude 422 
exposure. The findings of this meta-analysis demonstrate that acylated ghrelin is suppressed in 423 
hypoxia compared with normoxia but that total ghrelin concentrations remain unchanged. Total 424 
ghrelin consists of the combined levels of des-acyl ghrelin and acylated ghrelin, and recent 425 
research has found that des-acyl ghrelin can inhibit the orexigenic effects of acylated ghrelin 426 
by targeting the arcuate nucleus, independently of the growth hormone secretagogue receptor 427 
(Fernandez et al., 2016). The opposing effects of these hormones suggest that physiologically 428 
relevant changes in ghrelin constituents may be masked by the measurement of total ghrelin. It 429 
would therefore be beneficial for further research in this area to differentiate between the 430 
ghrelin constituents.  431 
 Fasting insulin concentrations were found to be elevated with hypoxic exposure 432 
compared with normoxia, and this effect was positively associated with the severity of 433 
hypoxia. Additionally, a larger effect was observed in acclimatised participants than in 434 
unacclimatised participants. However, this observation may be confounded by the fact that 435 
studies that tend to recruit acclimatised participants often use higher altitudes. These higher 436 
altitudes may be the factor causing the larger increase in insulin concentrations, which is 437 
supported by the meta-regression between hypoxic severity and changes in insulin 438 
concentrations. Such increases in insulin concentration may contribute to the observed 439 
reductions in hunger during hypoxic exposure but could also represent a reduction in insulin 440 
sensitivity. An increase in fasted, but not postprandial insulin concentrations, suggests that 441 
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hepatic insulin sensitivity is more heavily influenced by hypoxia then peripheral insulin 442 
sensitivity (Matsuda & DeFronzo, 1999; Radziuk, 2014). Hypoxia has been shown to induce 443 
whole-body insulin resistance in mice (Murphy et al., 2017). Furthermore, the use of a 444 
hyperinsulinaemic, euglycaemic clamp in humans has demonstrated that an acute 30-min 445 
hypoxic exposure (resulting in a blood oxygen saturation of ~75%) rapidly reduces whole-446 
body insulin sensitivity by ~15% (Oltmanns et al., 2004). The reduction in insulin sensitivity 447 
could be due to catecholamine responses, adipose tissue inflammation, and/or HIF signalling 448 
(Murphy et al., 2017; Oltmanns et al., 2004). This reduction in insulin sensitivity may be 449 
transient, as others have shown that following an acute hypoxic exposure, insulin sensitivity 450 
under normoxia is increased compared to continuous normoxia. Therefore, hypoxia may 451 
acutely reduce insulin sensitivity, with a subsequent “rebound” upon return to normoxia. 452 
Further work is required to establish whether chronic, sustained hypoxia reduces hepatic 453 
and/or peripheral insulin sensitivity. 454 
Interestingly, subgroup analysis revealed a larger increase in fasted insulin 455 
concentrations under conditions of simulated hypobaric hypoxia than terrestrial altitude or 456 
simulated normobaric hypoxia. Although further research is required, some evidence suggests 457 
that simulated hypobaric hypoxia induces greater physiological stress than simulated 458 
normobaric hypoxia (Coppel et al., 2015), which may contribute to the larger increases in 459 
fasted insulin levels under this condition. It also seems feasible that simulated hypobaric 460 
hypoxia may be a more potent physiological stressor than terrestrial altitude due to the 461 
immediacy of the hypoxic exposure (i.e., walking through the door of an environmental 462 
chamber rather than ascending more gradually to terrestrial altitude by transport or trekking). 463 
Despite these potential effects, other differences between the studies assessing fasted insulin 464 
concentrations may also have contributed to this observation, including the severity of 465 
hypoxia induced in the different experiments. 466 
 The findings of the current review provide support for the notion that leptin 467 
concentrations are not consistently affected by hypoxic exposure. From the studies included in 468 
this review it appears that shorter duration studies utilising simulated altitudes result in 469 
elevations of leptin concentrations compared with normoxia (Mekjavic et al., 2016; Snyder et 470 
al., 2008), whereas longer duration studies at terrestrial altitude result in reductions in leptin 471 
levels compared with normoxia (Benso et al., 2007; Castell et al., 2010; Vats et al., 2004). 472 
These observations concur with the hypothesis that hypoxia stimulates HIF-1, which can 473 
increase leptin concentrations. However chronic hypoxic exposure can suppress leptin 474 
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concentrations by reducing adiposity. This explains the lack of an overall effect in the current 475 
meta-analysis. Due to multiple confounding factors in the included studies, which were not 476 
possible to account for in the current analysis (e.g. sleep, cold, smoking status), further well 477 
designed research would be beneficial to elucidate the effects of hypoxia per se on circulating 478 
leptin concentrations in humans.  479 
In the current review the only hormones investigated which aligned with the observed 480 
reductions in hunger and energy intake were acylated ghrelin and insulin. Each of the other 481 
appetite-related hormones were not found to change significantly in hypoxia compared with 482 
normoxia. One recent study found that a high fat breakfast directly increased postprandial 483 
acylated ghrelin and reduced postprandial insulin concentrations at simulated altitude, 484 
compared with a high carbohydrate breakfast (Matu et al., 2017c). These alterations in hormone 485 
concentrations were associated with increased appetite perceptions during an exercise bout that 486 
simulated trekking activity. This research supports the conclusions of this review, and suggests 487 
that it may be beneficial for further future studies to focus on interventions to minimise altitude-488 
induced changes in acylated ghrelin and insulin concentrations in an attempt to augment energy 489 
intake, particularly during prolonged periods of hypoxic exposure.  490 
Some notable limitations must be acknowledged in this meta-analysis. First, the 491 
postprandial comparisons included within this review included a range of feeding protocols 492 
and observation durations. Although these factors did not appear to have any noticeable effect 493 
on the direction of the overall findings, it is possible that these factors may have influenced the 494 
findings of each individual study. For example, the studies that provided meals containing 495 
higher energy content or in the form of solid food would be expected to induce greater 496 
reductions in hunger than lower energy or liquid meals (Tieken et al., 2007). It remains unclear 497 
whether this would alter the effects of hypoxic exposure on the variables measured in this 498 
review when compared with a matched normoxic trial, but this remains an important 499 
consideration and an avenue for future investigation. Second, the hormones PP and CCK are 500 
proposed to exert anorexigenic effects but these hormones were not included in this meta-501 
analysis as only two studies met the inclusion criteria for each hormone. These studies both 502 
reported that hypoxic exposure suppressed concentrations of PP (Matu et al., 2017a; Riepl et 503 
al., 2012) and CCK (Aeberli et al., 2013; Riepl et al., 2012) in the fasted and postprandial states, 504 
suggesting that neither hormone plays a role in altitude-induced anorexia, as suppression of 505 
these hormones would be expected to increase hunger. Third, we decided to exclude self-506 
reported energy intake data and only include energy intake data from studies where it was 507 
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measured by the research team. In total 27 studies were excluded for this reason, and thus it 508 
may be argued that conclusions from this meta-analysis may be biased. However, this decision 509 
was made a-priori due to the various limitations associated with self-report methods (Hill & 510 
Davies, 2001) and recent conclusions that self-reported energy intake should not be used as a 511 
measure of energy intake in scientific research (Dhurandhar et al., 2016; Subar et al., 2015). 512 
Fourth, the statistical power of the analysis must be considered when interpreting the results, 513 
particularly with regard to the subgroup analysis. As few as two comparisons were included in 514 
some subgroups for analysis, and therefore may be underpowered. Fifth, as shown in Figure 7, 515 
many of the included studies were classified as high risk for random sequence generation, 516 
allocation concealment and blinding. However, it is important to note this this appraisal does 517 
not necessarily mean the studies were methodologically flawed as these factors are often not 518 
possible to incorporate during high altitude trekking studies. Finally, despite an extensive 519 
search returning 2834 records, we cannot guarantee that our search was completely exhaustive 520 
of the relevant literature. However, having searched the reference lists of all included studies 521 
we are confident to have included all available relevant studies.  522 
In conclusion, this meta-analysis reveals that exposure to hypoxia decreases hunger and 523 
energy intake compared with normoxia, and that these reductions are associated with depressed 524 
acylated ghrelin concentrations and elevated insulin concentrations. Given the hypothesised 525 
roles of these hormones in the control of appetite, these changes are plausible neuroendocrine 526 
signals mediating altitude-induced anorexia. It may be beneficial for future research to 527 
investigate interventions that increase acylated ghrelin concentrations and decrease insulin 528 
concentrations at altitude, with the aims of maintaining insulin sensitivity, and increasing 529 
appetite and energy intake to assist with the maintenance of energy balance.  530 
 531 
Financial Support 532 
This research received no specific grant from any funding agency, commercial or not-for-profit 533 
sectors. 534 
 535 
Conflict of Interest 536 
The authors declare no conflicts of interest.  537 
19 
 
References  
Adam TC, Toledo-Corral C, Lane CJ et al. (2009) Insulin sensitivity as an independent 
predictor of fat mass gain in Hispanic adolescents. Diabetes care 32, 2114-2115. 
*Aeberli I, Erb A, Spliethoff K et al. (2013) Disturbed eating at high altitude: influence of 
food preferences, acute mountain sickness and satiation hormones. Eur J Nut 52, 625-635. 
Air EL, Benoit SC, Blake Smith KA et al. (2002) Acute third ventricular administration of 
insulin decreases food intake in two paradigms. Pharmacol Biochem Behav 72, 423-429. 
Ades AE, Lu G, Higgins JP (2005) The interpretation of random-effects meta-analysis in 
decision models. Med Decis Mak 25, 646-654. 
*Bailey DM, Ainslie PN, Jackson SK et al. (2004) Evidence against redox regulation of 
energy homoeostasis in humans at high altitude. Clin Sci 107, 589-600. 
*Bailey DP, Smith LR, Chrismas BC et al. (2015) Appetite and gut hormone responses to 
moderate-intensity continuous exercise versus high-intensity interval exercise, in normoxic 
and hypoxic conditions. Appetite 89, 237-245. 
*Benso A, Broglio F, Aimaretti G et al. (2007) Endocrine and metabolic responses to 
extreme altitude and physical exercise in climbers. Eur J Endocrinol 157, 733-740. 
Berthoud HR (2006) Homeostatic and non-homeostatic pathways involved in the control of 
food intake and energy balance. Obesity 14, 197-200. 
*Braun B, Rock PB, Zamudio S et al. (2001) Women at altitude: short-term exposure to 
hypoxia and/or alpha(1)-adrenergic blockade reduces insulin sensitivity. J Appl Phsiol 91, 
623-631. 
Butterfield GE, Gates J, Fleming S et al. (1992) Increased energy intake minimizes weight 
loss in men at high altitude. J Appl Physiol 72, 1741-1748. 
*Castell LM, Thake CD, Ensign W (2010) Biochemical markers of possible 
immunodepression in military training in harsh environments. Mil Med 175, 158-165. 
Cohen J (1969) Statistical power analysis for the behavioural sciences. Hillsdale (NJ): 
Lawrence Erlbaum Associates. 
Coppel J, Hennis P, Gilbert-Kawai E, Grocott MPW (2015) The physiological effects of 
hypobaric hypoxia versus normobaric hypoxia: a systematic review of crossover trials. 
Extrem Physiol Med 4, 2. 
*Debevec T, Simpson EJ, Macdonald IA et al. (2014a) Exercise training during normobaric 
hypoxic confinement does not alter hormonal appetite regulation. PloS one 9, e98874. 
*Debevec T, Bali TC, Simpson EJ et al. (2014b) Separate and combined effects of 21-day 
bed rest and hypoxic confinement on body composition. Eur J Appl Physiol 114, 2411-2425. 
20 
 
*Debevec T, Simpson EJ, Mekjavic IB et al. (2016) Effects of prolonged hypoxia and bed 
rest on appetite and appetite-related hormones. Appetite 107, 28-37. 
Debevec T (2017) Hypoxia-Related Hormonal Appetite Modulation in Humans during Rest 
and Exercise: Mini Review. Front Physiol 8, 366. 
Deighton K, Stensel DJ (2014) Creating an acute energy deficit without stimulating 
compensatory increases in appetite: is there an optimal exercise protocol? Proc Nutr Soc 73, 
352-358. 
Dhurandhar NV, Brown AW, Thomas D et al. (2016) We Agree That Self-Reported Energy 
Intake Should Not Be Used as a Basis for Conclusions about Energy Intake in Scientific 
Research. J Nut 146, 1141-1142. 
Ettinger RH, Staddon JE (1982) Decreased feeding associated with acute hypoxia in rats. 
Physiol Behav 29, 455-458. 
Fernandez G, Cabral A, Cornejo MP et al. (2016) Des-Acyl Ghrelin Directly Targets the 
Arcuate Nucleus in a Ghrelin-Receptor Independent Manner and Impairs the Orexigenic 
Effect of Ghrelin. J Neuroendocrinol 28, 12349. 
Grosfeld A, Andre J, Hauguel-De Mouzon S et al. (2002) Hypoxia-inducible factor 1 
transactivates the human leptin gene promoter. J Biol Chem 277, 42953-42957. 
Hallschmid M, Higgs S, Thienel M, Ott V, Lehnert H (2012) Postprandial administration of 
intranasal insulin intensifies satiety and reduces intake of palatable snacks in women. 
Diabetes 61, 782-789. 
Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat 
Medicine 21, 1539-1558. 
Higgins JP, Altman DG, Sterne JA (2011) Chapter 8: Assessing risk of bias in included 
studies in Cochrane Handbook for Systematic Reviews of Interventions. vol. Version 5.1.0. 
Chichester, West Sussex Hoboken NJ : John Wiley &amp; Sons, [2008] ©2008. 
Hill RJ, Davies PS (2001) The validity of self-reported energy intake as determined using the 
doubly labelled water technique. Brit J Nut 85, 415-430. 
Hosoda H, Doi K, Nagaya N et al. (2004) Optimum collection and storage conditions for 
ghrelin measurements: octanoyl modification of ghrelin is rapidly hydrolyzed to desacyl 
ghrelin in blood samples. Clin Chem 50, 1077-1080. 
Klok MD, Jakobsdottir S, Drent ML (2007) The role of leptin and ghrelin in the regulation of 
food intake and body weight in humans: a review. Obes Rev 8, 21-34. 
*Larsen JJ, Hansen JM, Olsen NV et al. (1997) The effect of altitude hypoxia on glucose 
homeostasis in men. J Physiol 504, 241-249. 
21 
 
Liberati A, Altman DG, Tetzlaff J et al. (2009) The PRISMA statement for reporting 
systematic reviews and meta-analyses of studies that evaluate healthcare interventions: 
explanation and elaboration. BMJ 339. 
Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose 
tolerance testing: comparison with the euglycemic insulin clamp. Diabetes care 22, 1462-
1470. 
*Matu J, Deighton K, Ispoglou T et al. (2017a) The effect of moderate versus severe 
simulated altitude on appetite, gut hormones, energy intake and substrate oxidation in men. 
Appetite 113, 284-292. 
Matu J, O'Hara J, Hill N et al. (2017b) Changes in appetite, energy intake, body composition, 
and circulating ghrelin constituents during an incremental trekking ascent to high altitude. 
Eur J Appl Physiol 117, 1917–1928.  
Matu J, Deighton K, Ispoglou T et al. (2017c) A high fat breakfast attenuates the suppression 
of appetite and acylated ghrelin during exercise at simulated altitude. Physiol Behav 179, 
353-360. 
Mazzeo RS (2005) Altitude, exercise and immune function. Ex Immun Rev 11, 6-16. 
*Mekjavic IB, Amon M, Kölegård R et al. (2016) The effect of normobaric hypoxic 
confinement on metabolism, gut hormones and body composition. Front Physiol 7, 202. 
Monteiro MP, Batterham RL (2017) The Importance of the Gastrointestinal Tract in 
Controlling Food Intake and Regulating Energy Balance. Gastroenterology 152, 1707-1717. 
*Morishima T, Goto K (2016) Ghrelin, GLP-1, and leptin responses during exposure to 
moderate hypoxia. Appl Physiol, Nutrition, Metab 41, 375-381. 
Murphy AM, Thomas A, Crinion SJ et al. (2017) Intermittent hypoxia in obstructive sleep 
apnoea mediates insulin resistance through adipose tissue inflammation. Eur Respir J 49, 
DOI: 10.1183/13993003.01731-2016. 
Murphy KG, Bloom SR (2006) Gut hormones and the regulation of energy homeostasis. Nat 
444, 854-859. 
Oltmanns KM, Gehring H, Rudolf S et al. (2004) Hypoxia Causes Glucose Intolerance in 
Humans. Am J Respir Crit Care Med 169, 1231-1237. 
Pulfrey SM, Jones PJ (1996) Energy expenditure and requirement while climbing above 
6,000 m. J Appl Physiol 81, 1306-1311. 
Radziuk J (2014) Homeostastic model assessment and insulin sensitivity/resistance. Diabetes 
63, 1850-1854. 
*Riedl S, Kluge M, Schweitzer K et al. (2012) Adaptation of ghrelin and the GH/IGF axis to 
high altitude. Eur J Endocrinol 166, 969-976. 
22 
 
*Riepl RL, Fischer R, Hautmann H et al. (2012) Influence of acute exposure to high altitude 
on basal and postprandial plasma levels of gastroenteropancreatic peptides. PloS one 7, 
e44445. 
Rose MS, Houston CS, Fulco CS et al. (1988) Operation Everest. II: Nutrition and body 
composition. J Appl Physiol 65, 2545-2551. 
*Sawhney RC, Malhotra AS, Singh T et al. (1986) Insulin secretion at high altitude in man. 
Int J Biometeorol 30, 231-238. 
*Sawhney RC, Malhotra AS, Singh T (1991) Glucoregulatory hormones in man at high 
altitude. Eur J Appl Physiol Occup Physiol 62, 286-291. 
Semenza GL (2012) Hypoxia-inducible factors in physiology and medicine. Cell 148, 399-
408. 
Sergi G, Imoscopi A, Sarti S et al. (2010) Changes in total body and limb composition and 
muscle strength after a 6-8 weeks sojourn at extreme altitude (5000-8000 m). J Sports Med 
Phys Fit 50, 450-455. 
Sierra-Johnson J, Romero-Corral A, Somers VK et al. (2008) Last word on viewpoint: effect 
of altitude on leptin levels, does it go up or down? J Appl Physiol 105, 1691. 
*Shukla V, Singh SN, Vats P et al. (2005) Ghrelin and leptin levels of sojourners and 
acclimatized lowlanders at high altitude. Nut Neurosci 8, 161-165. 
*Simpson EJ, Debevec T, Eiken O, Mekjavic I, Macdonald IA (2016) PlanHab: the 
combined and separate effects of 16 days of bed rest and normobaric hypoxic confinement on 
circulating lipids and indices of insulin sensitivity in healthy men. J Appl Physiol 120, 947-
955. 
*Smith JD, Cianflone K, Martin J et al. (2011) Plasma adipokine and hormone changes in 
mountaineers on ascent to 5300 meters. Wilderness Environ Med 22, 107-114. 
*Snyder EM, Carr RD, Deacon CF et al. (2008) Overnight hypoxic exposure and glucagon-
like peptide-1 and leptin levels in humans. Appl Physiol, Nut, Metab 33, 929-935. 
*Spliethoff K, Meier D, Aeberli I et al. (2013) Reduced insulin sensitivity as a marker for 
acute mountain sickness? High Alt Med Biol 14, 240-250. 
Sterne JAC, Egger M, Moher D (2011) Chapter 10: Addressing reporting biases in Cochrane 
Handbook for Systematic Reviews of Interventions. vol. Version 5.1.0. Chichester, West 
Sussex Hoboken NJ : John Wiley &amp; Sons, [2008] ©2008. 
Subar AF, Freedman LS, Tooze JA et al. (2015) Addressing Current Criticism Regarding the 
Value of Self-Report Dietary Data. J Nut 145, 2639-2645. 
23 
 
Tieken SM, Leidy HJ, Stull AJ et al. (2007) Effects of solid versus liquid meal-replacement 
products of similar energy content on hunger, satiety, and appetite-regulating hormones in 
older adults. Horm Metab Res 39, 389-94. 
Tschop M, Morrison KM (2001) Weight loss at high altitude. Adv Exp Med Biol 502, 237-
247. 
Tschop M, Strasburger CJ, Hartmann G et al. (1998) Raised leptin concentrations at high 
altitude associated with loss of appetite. Lancet 352, 1119-1120. 
*Tschop M, Strasburger CJ, Topfer M et al. (2000) Influence of hypobaric hypoxia on leptin 
levels in men. Int J Obes Rel Metab Disord 24, 151. 
*Vats P, Singh SN, Shyam R et al. (2004) Leptin may not be responsible for high altitude 
anorexia. High Alt Med Biol 5, 90-92. 
*Wasse LK, Sunderland C, King JA et al. (2012) Influence of rest and exercise at a simulated 
altitude of 4,000 m on appetite, energy intake, and plasma concentrations of acylated ghrelin 
and peptide YY. J Appl Physiol 112, 552-559. 
Westerterp KR, Kayser B, Wouters L et al. (1994) Energy balance at high altitude of 6,542 
m. J Appl Physiol 77, 862-866. 
*Westerterp-Plantenga MS, Westerterp KR, Rubbens M et al. (1999) Appetite at "high 
altitude" [Operation Everest III (Comex-'97)]: a simulated ascent of Mount Everest. J Appl 
Physiol 87, 391-399. 
*Young PM, Rose MS, Sutton JR et al. (1989) Operation Everest II: plasma lipid and 
hormonal responses during a simulated ascent of Mt. Everest. J Appl Physiol 66, 1430-1435. 
Yu N, Ruan Y, Gao X et al. (2017) Systematic Review and Meta-Analysis of Randomized, 
Controlled Trials on the Effect of Exercise on Serum Leptin and Adiponectin in Overweight 
and Obese Individuals. Horm Metab Res 49, 164-173. 
Zaccagni L, Barbieri D, Cogo A et al. (2014) Anthropometric and body composition changes 
during expeditions at high altitude. High Alt Med Biol 15, 176-182. 
*Zaccaria M, Ermolao A, Bonvicini P et al. (2004) Decreased serum leptin levels during 
prolonged high altitude exposure. Eur J Appl Physiol 92, 249-253. 
 
* denotes that the study is included within the meta-analysis. 
  
24 
 
Figure 1. Forest plot of standardised mean differences (means ± 95% confidence intervals 
[CIs]) for studies evaluating the influence of hypoxic exposure on postprandial hunger scores 
compared with sea level. The size of each circle represents the relative weight of each 
comparison. The diamond represents a SMD (mean ± 95% CI) for the model. 
 
Figure 2. Forest plot of standardised mean differences (means ± 95% confidence intervals 
[CIs]) for studies evaluating the influence of hypoxic exposure on energy intake compared with 
sea level. The size of each circle represents the relative weight of each comparison. The 
diamond represents a SMD (mean ± 95% CI) for the model. 
 
Figure 3. Forest plot of standardised mean differences (means ± 95% confidence intervals 
[CIs]) for studies evaluating the influence of hypoxic exposure on postprandial acylated ghrelin 
concentrations compared with sea level. The size of each circle represents the relative weight 
of each comparison. The diamond represents a SMD (mean ± 95% CI) for the model. 
 
Figure 4. Univariable meta-regression for hypoxic severity versus the postprandial acylated 
ghrelin concentration responses to hypoxic exposure expressed as standardised mean 
difference (SMD).  
 
Figure 5. Forest plot of standardised mean differences (means ± 95% confidence intervals 
[CIs]) for studies evaluating the influence of hypoxic exposure on fasted insulin concentrations 
compared with sea level. The size of each circle represents the relative weight of each 
comparison. The diamond represents a SMD (mean ± 95% CI) for the model. 
 
Figure 6. Univariable meta-regression for hypoxic severity versus fasted insulin concentration 
responses to hypoxic exposure expressed as standardised mean difference (SMD).  
 
Figure 7. Risk of bias across expressed as a percentage across all included studies. White, grey 
and black bars indicate low, unclear and high risk of bias, respectively.  
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Table 1. Summary of moderator variable analysis for postprandial hunger, energy intake, postprandial acylated ghrelin and fasted insulin meta-analysis by subgroup and 
meta-regression 
Moderator Variable p value Comparison 
Postprandial hunger   
Acclimatisation status 0.183 Acclimatised (n = 3; SMD -0.382, 95% CI -0.749 to -0.015) 
  Unacclimatised (n = 11; SMD -0.110, 95% CI -0.270 to 0.050) 
Hypoxic method 0.396 Simulated hypobaric (n = 3; SMD -0.382, 95% CI -0.749 to -0.015) 
  Simulated normobaric (n = 9; SMD -0.151, 95% CI -0.330 to 0.028) 
  Terrestrial altitude (n = 2; SMD -0.001, 95% CI -0.457 to 0.455) 
Activity status 0.049 Passive (n = 6; SMD -0.350, 95% CI -0.598 to -0.103) 
Active (n = 8; SMD -0.051, 95% CI -0.216 to 0.114) 
Hypoxic severity 0.175 Meta-regression of altitude height vs. SMD (slope -0.0001, 95% CI -0.0002 to 0.0000)  
Duration of exposure 0.889 Meta-regression of duration of exposure vs. SMD (slope -0.0017, 95% CI -0.0224 to 0.0258)  
Energy intake   
Hypoxic method 0.833 Simulated normobaric (n = 6; SMD -0.531, 95% CI -1.014 to -0.047) 
  Terrestrial altitude (n = 2; SMD -0.448, 95% CI -1.045 to 0.149) 
Activity status 0.970 Passive (n = 2; SMD -0.489, 95% CI -1.207 to 0.230) 
  Active (n = 6; SMD -0.505, 95% CI -0.941 to -0.069) 
Hypoxic severity 0.289 Meta-regression of altitude height vs. SMD (slope -0.0003, 95% CI -0.0007 to 0.0002)  
Duration of exposure 0.056 Meta-regression of duration of exposure vs. SMD (slope 0.0509, 95% CI -0.0014 to 0.1031)  
Postprandial acylated ghrelin   
Activity status 0.450 Passive (n = 2; SMD -0.207, 95% CI -0.321 to -0.092) 
  Active (n = 5; SMD -0.145, 95% CI -0.258 to -0.031) 
Hypoxic severity 0.010 Meta-regression of hypoxic severity vs. SMD (slope -0.0001, 95% CI -0.0002 to -0.0000)  
Duration of exposure 0.293 Meta-regression of duration of exposure vs. SMD (slope -0.4196, 95% CI -1.2018 to 0.3625)  
Fasted insulin   
Acclimatisation status <0.0005 Acclimatised (n = 12; SMD 1.016, 95% CI 0.582 to 1.450) 
  Unacclimatised (n = 22; SMD 0.121, 95% CI -0.121 to 0.363) 
Hypoxic method <0.0005 Simulated hypobaric (n = 6; SMD 1.052, 95% CI 0.638 to 1.467) 
  Simulated normobaric (n = 7; SMD -0.215, 95% CI -0.913 to 0.361) 
  Terrestrial altitude (n = 21; SMD 0.443, 95% CI 0.162 to 0.724) 
Activity status 0.107 Passive (n = 16; SMD 0.619, 95% CI 0.184 to 1.055) 
  Active (n = 18; SMD 0.211, 95% CI -0.027 to 0.450) 
Hypoxic severity 0.020 Meta-regression of hypoxic severity vs. SMD (slope 0.0003, 95% CI 0.0000 to 0.0005)  
Duration of exposure 0.377 Meta-regression of duration of exposure vs. SMD (slope 0.0079, 95% CI -0.0096 to 0.0255)  
26 
 
Figure 1  
27 
 
Figure 2 
 
 
  
28 
 
Figure 3 
 
 
 
  
29 
 
Figure 4 
 
 
  
30 
 
Figure 5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
31 
 
Figure 6 
 
 
  
32 
 
Figure 7 
 
 
  
33 
 
Supplementary figure 1 
 
 
  
  
34 
 
Article title: The effects of hypoxia on hunger perceptions, appetite-related hormone concentrations, and energy intake: a 
systematic review and meta-analysis 
Journal: Appetite 
Authors names: Jamie Matu, Javier T. Gonzalez, Theocharis Ispoglou, Lauren Duckworth and Kevin Deighton 
Corresponding author: Dr Kevin Deighton, Institute for Sport Physical Activity & Leisure, Leeds Beckett University, 
Leeds, LS6 3QS, United Kingdom (email: K.Deighton@leedsbeckett.ac.uk) 
 
Supplementary material 
Search strategy: PubMed and The Cochrane Library as well as MEDLINE, SPORTDiscus, PsycINFO and 
CINAHL, via EBSCOhost 
 
Search terms: 
1. Altitude 
2. Hypoxia  
3. Hypoxic  
4. Mountaineering 
5. Appetite 
6. Appetite hormones 
7. Ghrelin 
8. Acylated ghrelin 
9. GLP-1 
10. Glucagon like peptide-1  
11. Peptide YY 
12. PYY 
13. Leptin 
14. Pancreatic polypeptide 
15. Insulin 
16. CCK 
17. Cholecystokinin 
18. Hunger 
19. Satiety 
20. Energy intake 
21. Food intake 
22. Energy balance 
Searches: 
A) 1 and 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 
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B) 2 and 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 
C) 3 and 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 
D) 4 and 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 
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Article title: The effects of hypoxia on hunger perceptions, appetite-related hormone concentrations, and energy intake: a systematic review and meta-analysis 
Journal: Appetite 
Authors names: Jamie Matu, Javier T. Gonzalez, Theocharis Ispoglou, Lauren Duckworth and Kevin Deighton 
Corresponding author: Dr Kevin Deighton, Institute for Sport Physical Activity & Leisure, Leeds Beckett University, Leeds, LS6 3QS, United Kingdom (email: 
K.Deighton@leedsbeckett.ac.uk) 
 
Supplementary Table 1. Effects of hypoxic exposure on fasted hunger and fasted hormone concentrations  
Study Participants Intervention Variables assessed 
Design Hypoxic 
severity 
/m 
Duration Acclimatisation 
status 
Hypoxic 
method 
Activity 
status 
Hunger 
/mm 
GLP-1 
/pgml-1 
Insulin 
/µUmL-1. 
Leptin 
/pgml-1 
PYY 
/pgml-1 
Total 
ghrelin 
/pgml-1 
Aeberli et al. 
2013-1  
22 men and 
women 
combined  
Longitudinal 4559 2 days Unacclimatised Terrestrial 
altitude 
Active SL: 59 (8) 
ALT: 43 (8) 
 
 
- - - - - 
Aeberli et al. 
2013-2  
22 men and 
women 
combined 
Longitudinal 4559 4 days Unacclimatised Terrestrial 
altitude 
Active SL: 59 (8) 
ALT: 64 (6) 
 
 
- - - - - 
Bailey et al. 
2004  
7 men and 
women 
combined 
Longitudinal 4780 11 days Unacclimatised Terrestrial 
altitude 
Active - SL: 68.2 
(29.7) 
ALT: 89.3 
(44.8) 
SL: 13.3 
(5.6) 
ALT: 10.4 
(6.8) 
SL: 42 (19) 
ALT: 34 
(13) #a 
- - 
Benso et al. 
2007  
9 men Longitudinal 5200 61 days Acclimatised Terrestrial 
altitude 
Active - - SL: 10.1 
(2.4) 
ALT: 10.9 
(2.4) 
SL: 777 
(197) 
ALT: 606 
(209) 
- SL: 147 
(26) 
ALT: 158 
(45) 
Braun et al. 
2001  
12 females Longitudinal 4300 16 hours Unacclimatised Simulated 
hypobaric 
Passive - - SL: 3.3 
(1.5) 
ALT: 5.0 
(2.0) 
- - - 
Castell et al. 
2010-1  
35 men Longitudinal 2134 1 day Unacclimatised Terrestrial 
altitude 
Active - - - SL: 2 (2) 
ALT: 2 (1)  
 
 
- - 
Castell et al. 
2010-2  
56 men Longitudinal 2743 14 days Unacclimatised Terrestrial 
altitude 
Active - - - SL: 2 (2) 
ALT: 1 (1)  
 
 
- - 
Castell et al. 
2010-3  
53 men Longitudinal 2743 28 days Unacclimatised Terrestrial 
altitude 
Active - - - SL: 2 (2) 
ALT: 2 (1) 
 
- - 
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Study Participants Intervention Variables assessed 
Design Hypoxic 
severity 
/m 
Duration Acclimatisation 
status 
Hypoxic 
method 
Activity 
status 
Hunger 
/mm 
GLP-1 
/pgml-1 
Insulin 
/µUmL-1. 
Leptin 
/pgml-1 
PYY 
/pgml-1 
Total 
ghrelin 
/pgml-1 
 
Debevec et al. 
2014a-1  
11 men Longitudinal 4000 1 day Unacclimatised Simulated 
normobaric 
Active SL: 40.2 
(36.4) 
ALT: 45.3 
(31.4) 
- - - - - 
Debevec et al. 
2014a-2  
11 men Longitudinal 4000 21 days Unacclimatised Simulated 
normobaric 
Active SL: 40.2 
(36.4) 
ALT: 44.3 
(33.6) 
 
- - - - - 
Debevec et al. 
2014a-3  
11 men Longitudinal 4000 1 day Unacclimatised Simulated 
normobaric 
Passive SL: 49.9 
(29.6)  
ALT: 46.4 
(40.0) 
- - - - - 
Debevec et al. 
2014a-4  
11 men Longitudinal 4000 21 days Unacclimatised Simulated 
normobaric 
Passive SL: 49.9 
(29.6) 
ALT: 47.5 
(40.1) 
- - - - - 
Debevec et al. 
2014b-1  
8 men Longitudinal 4000 1 day Unacclimatised Simulated 
normobaric 
Active SL: 45.6 
(24.0) 
ALT: 47.0 
(23.2) 
SL: 12.0 
(21.8) 
ALT: 12.4 
(19.3) 
SL: 10.6 
(2.0) 
ALT: 10.9 
(1.9) 
SL: 4910 
(3530) 
ALT: 6920 
(4220) 
SL: 97.8 
(21.8) 
ALT: 93.8 
(13.3) 
SL: 911 
(239) 
ALT: 817 
(162) 
Debevec et al. 
2014b-2  
8 men Longitudinal 4000 10 days Unacclimatised Simulated 
normobaric 
Active SL: 45.6 
(24.0) 
ALT: 50.5 
(20.2) 
SL: 12.0 
(21.8) 
ALT: 9.1 
(12.6) 
SL: 10.6 
(2.0) 
ALT: 8.7 
(1.9) 
SL: 4910 
(3530) 
ALT: 3650 
(2020) 
SL: 97.8 
(21.8) 
ALT: 
102.2 
(13.6) 
SL: 911 
(239) 
ALT: 876 
(247) 
Debevec et al. 
2014b-3  
6 men Longitudinal 4000 1 day Unacclimatised Simulated 
normobaric 
Passive SL: 44.1 
(10.9) 
ALT: 58.3 
(19.0) 
SL: 6.3 
(7.0) 
ALT: 8.6 
(7.7) 
SL: 10.4 
(1.5) 
ALT: 12.1 
(1.9) 
SL: 3600 
(1220) 
ALT: 5030 
(2140) 
SL: 101.7 
(25.6) 
ALT: 96.8 
(31.2) 
SL: 705 
(160) 
ALT: 743 
(145) 
Debevec et al. 
2014b-4  
6 men Longitudinal 4000 10 days Unacclimatised Simulated 
normobaric 
Passive SL: 44.1 
(10.9) 
ALT: 33.8 
(25.9) 
SL: 6.3 
(7.0) 
ALT: 5.5 
(6.7) 
SL: 10.4 
(1.5) 
ALT: 8.1 
(1.1) 
SL: 3600 
(1220) 
ALT: 3490 
(1360) 
SL: 101.7 
(25.6) 
ALT: 93.8 
(20.7) 
SL: 705 
(160) 
ALT: 782 
(155) 
Debevec et al. 
2016-1  
11 men Longitudinal 4000 16 days Unacclimatised Simulated 
normobaric 
Active SL: 50.3 
(37.5) 
ALT: 43.2 
(36.6) 
SL: 7.0 
(3.8) 
ALT: 5.6 
(1.7) 
- SL: 4487 
(2977) 
ALT: 3449 
(2891) 
SL: 97.5 
(34.7) 
ALT: 
100.4 
(35.4) 
SL: 778 
(289) 
ALT: 845 
(296) 
Debevec et al. 
2016-2  
11 men Longitudinal 4000 16 days Unacclimatised Simulated 
normobaric 
Passive SL: 54.5 
(26.7) 
ALT: 51.4 
(37.5) 
SL: 6.2 
(5.1) 
ALT: 5.8 
(2.5) 
- SL: 5192 
(4316) 
ALT: 4431 
(3689) 
SL: 128.6 
(45.9) 
SL: 761 
(242) 
ALT: 852 
(254) 
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Study Participants Intervention Variables assessed 
Design Hypoxic 
severity 
/m 
Duration Acclimatisation 
status 
Hypoxic 
method 
Activity 
status 
Hunger 
/mm 
GLP-1 
/pgml-1 
Insulin 
/µUmL-1. 
Leptin 
/pgml-1 
PYY 
/pgml-1 
Total 
ghrelin 
/pgml-1 
ALT: 
135.0 
(40.8) 
Larsen et al. 
1997-1  
8 men Longitudinal 4559 2 days Unacclimatised True 
altitude 
Passive - - SL: 6.8 
(1.3) 
ALT: 10.5 
(2.0) 
- - - 
Larsen et al. 
1997-2  
8 men Longitudinal 4559 7 days Unacclimatised True 
altitude 
Passive - - SL: 6.8 
(1.3) 
ALT: 5.2 
(2.2) 
 
- - - 
Mekjavic et al. 
2016  
11 men Longitudinal 3400 10 days Unacclimatised Simulated 
normobaric 
Passive - SL: 4.2 
(14.0) 
ALT: 6.2 
(18.7) 
SL: 2.7 
(4.4) 
ALT: 2.7 
(5.4) 
SL: 2600 
(696) 
ALT: 3630 
(862) 
SL: 97.7 
(90.2) 
ALT: 
107.2 
(64.3) 
SL: 1030 
(107) 
ALT: 1177 
(107) 
Riedl et al. 
2012-1  
33 men and 
women 
combined 
Longitudinal 
 
3440 4 days Unacclimatised Terrestrial 
altitude 
Active - - SL: 6.2 
(1.9) 
ALT: 5.9 
(1.9) 
- - SL: 111 
(45) 
ALT: 119 
(57) 
Riedl et al. 
2012-2  
28 men and 
women 
combined 
Longitudinal 
 
5050 14 days Unacclimatised Terrestrial 
altitude 
Active - - SL: 6.2 
(1.9) 
ALT: 6.6 
(2.4) 
- - SL: 111 
(45) 
ALT: 150 
(70) 
Riepl et al. 
2012  
5 men Longitudinal 3454 19 hours Unacclimatised Terrestrial 
altitude 
Passive - - - - - SL: 32 (11) 
ALT: 27 
(8) 
Sawhney et al. 
1986  
10 men Longitudinal 3500 14 days Unacclimatised Terrestrial 
altitude 
Passive - - SL: 7.4 
(5.4)  
ALT: 6.2 
(2.4) 
- - - 
Sawhney et al. 
1991-1  
15 men Longitudinal 3500 3 days Acclimatised Terrestrial 
altitude 
Passive - - SL: 9.1 
(1.2) 
ALT: 13.6 
(1.4) 
- - - 
Sawhney et al. 
1991-2  
15 men Longitudinal 3500 21 days Acclimatised Terrestrial 
altitude 
Passive - - SL: 9.1 
(1.2) 
ALT: 10.0 
(1.2) 
- - - 
Sawhney et al. 
1991-3  
15 men Longitudinal 5080 30 days Acclimatised Terrestrial 
altitude 
Passive - - SL: 9.1 
(1.2) 
ALT: 11.9 
(1.4) 
- - - 
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Study Participants Intervention Variables assessed 
Design Hypoxic 
severity 
/m 
Duration Acclimatisation 
status 
Hypoxic 
method 
Activity 
status 
Hunger 
/mm 
GLP-1 
/pgml-1 
Insulin 
/µUmL-1. 
Leptin 
/pgml-1 
PYY 
/pgml-1 
Total 
ghrelin 
/pgml-1 
Sawhney et al. 
1991-4  
15 men Longitudinal 5080 41 days Acclimatised Terrestrial 
altitude 
Passive - - SL: 9.1 
(1.2) 
ALT: 9.8 
(1.4) 
- - - 
Shukla et al. 
2005-1  
25 men Longitudinal 3600 2 days Unacclimatised Terrestrial 
altitude 
Passive - - - SL: 3500 
(2000) 
ALT: 3740 
(1880) 
- SL: 1282 
(554) 
ALT: 836 
(564) 
Shukla et al. 
2005-2  
25 men Longitudinal 4300 4 days Unacclimatised Terrestrial 
altitude 
Passive - - - SL: 3500 
(2000) 
ALT: 5350 
(1980) 
- SL: 1282 
(554) 
ALT: 733 
(527) 
Shukla et al. 
2005-3  
25 men Longitudinal 4300 11 days Unacclimatised Terrestrial 
altitude 
Passive - - - SL: 3500 
(2000) 
ALT: 5130 
(1840) 
- SL: 1282 
(554) 
ALT: 997 
(653) 
Simpson et al. 
2016-1 
11 men Longitudinal 4000 17 days Unacclimatised Simulated 
normobaric 
Active - - SL: 12.1 
(3.2) 
ALT: 10.7 
(4.8) 
- - - 
Simpson et al. 
2016-2 
11 men Longitudinal 4000 17 days Unacclimatised Simulated 
normobaric 
Passive - - SL: 12.4 
(4.3) 
ALT: 11.9 
(2.6) 
- - - 
Smith et al. 
2011-1  
10 men and 
women 
combined 
Longitudinal 4000 3 days Unacclimatised Terrestrial 
altitude 
Active - - SL: 2.1 
(0.3) 
ALT: 2.0 
(0.5) 
SL: 3500 
(2010) 
ALT: 3220 
(2250) 
- - 
Smith et al. 
2011-2  
10 men and 
women 
combined 
Longitudinal 4750 6 days Unacclimatised Terrestrial 
altitude 
Active - - SL: 2.1 
(0.3) 
ALT: 2.2 
(0.8) 
SL: 3500 
(2010) 
ALT: 3450 
(1800) 
- - 
Smith et al. 
2011-3  
10 men and 
women 
combined 
Longitudinal 5300 9 days Unacclimatised Terrestrial 
altitude 
Active - - SL: 2.1 
(0.3) 
ALT: 2.4 
(0.7) 
SL: 3500 
(2010) 
ALT: 3640 
(3000) 
- - 
Snyder et al. 
2008  
25 men and 
women 
combined 
Longitudinal 4100 17 hours Unacclimatised Simulated 
normobaric 
Passive - - - SL: 5 (1) 
ALT: 8 (2) 
 
 
- - 
Spliethoff et 
al. 2013-1  
9 men Longitudinal 4559 2 days Unacclimatised Terrestrial 
altitude 
Passive - - SL: 5.3 
(1.4) 
ALT: 7.0 
(1.4) 
- - - 
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Study Participants Intervention Variables assessed 
Design Hypoxic 
severity 
/m 
Duration Acclimatisation 
status 
Hypoxic 
method 
Activity 
status 
Hunger 
/mm 
GLP-1 
/pgml-1 
Insulin 
/µUmL-1. 
Leptin 
/pgml-1 
PYY 
/pgml-1 
Total 
ghrelin 
/pgml-1 
Spliethoff et 
al. 2013-2  
9 men Longitudinal 4559 4 days  Unacclimatised Terrestrial 
altitude 
Passive - - SL: 5.3 
(1.4) 
ALT: 6.2 
(1.5) 
- - - 
Tschop et al. 
2000  
20 men Longitudinal 4559 22 hours Unknown Terrestrial 
altitude 
Active - - - SL: 1220 
(850) 
ALT: 2060 
(1521) 
- - 
Vats et al. 
2004-1  
10 men Longitudinal 3600 2 days Unacclimatised Terrestrial 
altitude 
Passive - - SL: 5.5 
(2.9) 
ALT: 7.1 
(3.4) 
SL: 4500 
(2941) 
ALT: 1310 
(885) 
- - 
Vats et al. 
2004-2  
10 men Longitudinal 3600 7 days Unacclimatised Terrestrial 
altitude 
Passive - - SL: 5.5 
(2.9) 
ALT: 9.0 
(8.1) 
SL: 4500 
(2941) 
ALT: 1800 
(1708) 
- - 
Vats et al. 
2004-3  
10 men Longitudinal 4580 9 days Unacclimatised Terrestrial 
altitude 
Active - - SL: 5.5 
(2.9) 
ALT: 5.9 
(3.5) 
SL: 4500 
(2941) 
ALT: 1720 
(1107) 
- - 
Westerterp-
Plantenga et 
al. 1999-1  
8 men Longitudinal 5000 4 days Acclimatised Simulated 
hypobaric 
Passive SL: 75.8 
(7.3) 
ALT: 68.0 
(5.7) 
- - - - - 
Westerterp-
Plantenga et 
al. 1999-2  
8 men Longitudinal 6000 11 days Acclimatised Simulated 
hypobaric 
Passive SL: 75.8 
(7.3) 
ALT: 62.1 
(4.3) 
- - - - - 
Westerterp-
Plantenga et 
al. 1999-3  
8 men Longitudinal 7000 17 days Acclimatised Simulated 
hypobaric 
Passive SL: 75.8 
(7.3) 
ALT: 53.5 
(5.3) 
- - - - - 
Young et al. 
1989-1  
6 men Longitudinal 4280 7 days Acclimatised Simulated 
hypobaric 
Active - - SL: 5.9 
(0.7) 
ALT: 6.8 
(2.5) 
- - - 
Young et al. 
1989-2  
6 men Longitudinal 5572 16 days Acclimatised Simulated 
hypobaric 
Active - - SL: 5.9 
(0.7) 
ALT: 9.7 
(2.8) 
- - - 
Young et al. 
1989-3  
6 men Longitudinal 6509 25 days Acclimatised Simulated 
hypobaric 
Active - - SL: 5.9 
(0.7) 
ALT: 11.2 
(3.3) 
- - - 
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Study Participants Intervention Variables assessed 
Design Hypoxic 
severity 
/m 
Duration Acclimatisation 
status 
Hypoxic 
method 
Activity 
status 
Hunger 
/mm 
GLP-1 
/pgml-1 
Insulin 
/µUmL-1. 
Leptin 
/pgml-1 
PYY 
/pgml-1 
Total 
ghrelin 
/pgml-1 
Young et al. 
1989-4  
6 men Longitudinal 7753 32 days Acclimatised Simulated 
hypobaric 
Active - - SL: 5.9 
(0.7) 
ALT: 11.4 
(4.8) 
- - - 
Young et al. 
1989-5  
6 men Longitudinal 7753 40 days Acclimatised Simulated 
hypobaric 
Active - - SL: 5.9 
(0.7) 
ALT: 12.0 
(6.3) 
- - - 
Zaccaria et al. 
2004-1  
12 men Longitudinal 5050 1.6 days Acclimatised True 
altitude 
Active - - SL: 6.3 
(1.9) 
ALT: 6.8 
(2.7) 
SL: 1880 
(1120)  
ALT: 1210 
(1040) 
- - 
Zaccaria et al. 
2004-2  
12 men Longitudinal 5050 14 days Acclimatised True 
altitude 
Active - - SL: 6.3 
(1.9) 
ALT: 7.2 
(1.4) 
SL: 1880 
(1120) 
ALT: 1060 
(740) 
 
- - 
Data are mean (SD); RCT = randomised controlled trial, SL = sea-level, ALT = altitude 
 
 
 
 
 
 
 
 
 
 
 
42 
 
Supplementary Table 2. Effects of hypoxic exposure on postprandial hunger, postprandial hormone concentration and energy intake 
Study Participants Intervention Variables assessed 
Design Hypoxic 
severity 
/m 
Duration Acclimatisation 
status 
Hypoxic 
method 
Activity 
status 
Hunger 
/mm 
GLP-1 
/pgml-1 
Insulin 
/µUmL-1. 
PYY 
/pgml-1 
Acylated 
ghrelin 
/pgml-1 
Total 
ghrelin 
/pgml-1 
Energy 
intake 
/kJ 
Aeberli et al. 
2013-1  
22 men and 
women 
combined  
Longitudinal 4559 2 days Unacclimatised Terrestrial 
altitude 
Active SL: 45 
(34) 
ALT: 37 
(31) 
- - - - - SL: 3983 
(1916) 
ALT: 
2690 
(1289) 
Aeberli et al. 
2013-2  
22 men and 
women 
combined 
Longitudinal 4559 4 days Unacclimatised Terrestrial 
altitude 
Active SL: 45 
(34) 
ALT: 52 
(31) 
- - - - - SL: 3983 
(1916) 
ALT: 
3724 
(1247) 
Bailey et al. 
2015-1  
12 men RCT 2980 50 
minutes 
Unacclimatised Simulated 
normobaric 
Active 
(moderat
e 
intensity) 
SL: 39 
(14) 
ALT: 40 
(16) 
SL: 164 
(74) 
ALT: 163 
(80) 
SL: 12 (8) 
ALT: 14 
(9) 
SL: 130 
(52) 
ALT: 127 
(5) 
SL: 55 
(55) 
ALT: 49 
(53) 
- - 
Bailey et al. 
2015-2  
12 men RCT 2980 50 
minutes 
Unacclimatised Simulated 
normobaric 
Active 
(high 
intensity) 
SL: 32 
(15) 
ALT: 30 
(14) 
SL: 169 
(76) 
ALT: 168 
(76) 
SL: 10 (6) 
ALT: 10 
(5) 
SL: 118 
(40) 
ALT: 138 
(52) 
SL: 52 
(44) 
ALT: 48 
(57) 
- - 
Debevec et al. 
2014b-2  
8 men Longitudinal 4000 10 days Unacclimatised Simulated 
normobaric 
Active - SL: 19 
(24) 
ALT: 17 
(15) 
SL: 52 
(16) 
ALT: 40 
(8) 
SL: 121 
(30) 
ALT: 124 
(20) 
- SL: 751 
(165) 
ALT: 734 
(163) 
- 
Debevec et al. 
2014b-4  
6 men Longitudinal 4000 10 days Unacclimatised Simulated 
normobaric 
Passive - SL: 13 (7) 
ALT: 15 
(8) 
SL: 55 
(23) 
ALT: 43 
(11) 
SL: 126 
(35) 
ALT: 124 
(29) 
- SL: 647 
(94) 
ALT: 695 
(132) 
- 
Debevec et al. 
2016-1  
11 men Longitudinal 4000 16 days Unacclimatised Simulated 
normobaric 
Active SL: 46 
(32) 
ALT: 48 
(34) 
SL: 17 (8) 
ALT: 18 
(7) 
- SL: 121 
(37) 
ALT: 139 
(76) 
- SL: 621 
(237) 
ALT: 636 
(199) 
SL: 1120 
(478) 
ALT: 
1142 
(478) 
Debevec et al. 
2016-2  
11 men Longitudinal 4000 16 days Unacclimatised Simulated 
normobaric 
Passive SL: 47 
(27) 
ALT: 46 
(34) 
SL: 18 
(12) 
ALT: 14 
(7)  
- SL: 157 
(48) 
ALT: 159 
(46) 
- SL: 583 
(169) 
ALT: 632 
(160) 
SL: 1075 
(344) 
ALT: 
1017 
(408) 
 
Matu et al. 
2017a-1  
12 men RCT 2150 5 hours Unacclimatised Simulated 
normobaric 
Active SL: 42 
(27) 
ALT: 45 
(28) 
SL: 92 
(50) 
ALT: 96 
(52) 
SL: 17 
(16) 
ALT: 16 
(15) 
- SL: 97 
(59) 
ALT: 94 
(59) 
- SL: 7358 
(1789) 
ALT: 
7390 
(1226) 
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Study Participants Intervention Variables assessed 
Design Hypoxic 
severity 
/m 
Duration Acclimatisation 
status 
Hypoxic 
method 
Activity 
status 
Hunger 
/mm 
GLP-1 
/pgml-1 
Insulin 
/µUmL-1. 
PYY 
/pgml-1 
Acylated 
ghrelin 
/pgml-1 
Total 
ghrelin 
/pgml-1 
Energy 
intake 
/kJ 
Matu et al. 
2017a-2  
12 men RCT 4300 5 hours Unacclimatised Simulated 
normobaric 
Active SL: 42 
(27) 
ALT: 34 
(27) 
SL: 92 
(50) 
ALT: 93 
(54) 
SL: 17 
(16) 
ALT: 18 
(12) 
- SL: 97 
(59) 
ALT: 56 
(33) 
- SL: 7358 
(1789) 
ALT: 
3728 
(3179) 
Mekjavic et al. 
2016  
11 men Longitudinal 3400 10 days Unacclimatised Simulated 
normobaric 
Passive - SL: 6  
(16) 
ALT: 8 
(19) 
SL: 41 
(71) 
ALT: 62 
(99) 
- - - - 
Morishima & 
Goto 2016  
8 men RCT 2540 7 hours Unacclimatised Simulated 
normobaric 
Passive SL: 40  
(5) 
ALT: 38 
(7) 
SL: 16  
(4) 
ALT: 17 
(5) 
- - SL: 22  
(9) 
ALT: 20 
(9) 
- - 
Riepl et al. 
2012  
5 men Longitudinal 3454 19 hours Unacclimatised Terrestrial 
altitude 
Passive - - - - - SL: 26  
(7) 
ALT: 19 
(6) 
- 
Simpson et al. 
2016-1 
11 men Longitudinal 4000 17 days Unacclimatised Simulated 
normobaric 
Active - - SL: 67.1 
(22.8) 
ALT: 
58.9 
(24.9) 
- - -  
Simpson et al. 
2016-2 
11 men Longitudinal 4000 17 days Unacclimatised Simulated 
normobaric 
Passive - - SL: 73.0 
(32.6) 
ALT: 
77.9 
(38.5) 
- - -  
Spliethoff et al. 
2013-1  
9 men Longitudinal 4559 2 days Unacclimatised Terrestrial 
altitude 
Passive - - SL: 10  
(7) 
ALT: 9 
(5) 
- - - - 
Spliethoff et al. 
2013-2  
9 men Longitudinal 4559 4 days  Unacclimatised Terrestrial 
altitude 
Passive - - SL: 10  
(7) 
ALT: 12 
(7) 
- - - - 
Wasse et al. 
2012-1  
10 men RCT 4000 7 hours Unacclimatised Simulated 
normobaric 
Passive SL: 50  
(8) 
ALT: 39 
(17) 
- - SL: 125 
(30) 
ALT: 113 
(42) 
SL: 109 
(79) 
ALT: 85 
(61) 
- SL: 7535 
(2112) 
ALT: 
5504 
(2427) 
Wasse et al. 
2012-2  
10 men RCT 4000 7 hours Unacclimatised Simulated 
normobaric 
Active SL: 44 
(18) 
ALT: 36 
(19) 
- - SL: 133 
(44) 
ALT: 124 
(40) 
SL: 92 
(58) 
ALT: 80 
(71) 
- SL: 7909 
(2599) 
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Study Participants Intervention Variables assessed 
Design Hypoxic 
severity 
/m 
Duration Acclimatisation 
status 
Hypoxic 
method 
Activity 
status 
Hunger 
/mm 
GLP-1 
/pgml-1 
Insulin 
/µUmL-1. 
PYY 
/pgml-1 
Acylated 
ghrelin 
/pgml-1 
Total 
ghrelin 
/pgml-1 
Energy 
intake 
/kJ 
ALT: 
5084 
(1952) 
Westerterp-
Plantenga et al. 
1999-1  
8 men Longitudinal 5000 4 days Acclimatised Simulated 
hypobaric 
Passive SL: 44 
(24) 
ALT: 38 
(12) 
- - - - - - 
Westerterp-
Plantenga et al. 
1999-2  
8 men Longitudinal 6000 11 days Acclimatised Simulated 
hypobaric 
Passive SL: 44 
(24) 
ALT: 36 
(9) 
- - - - - - 
Westerterp-
Plantenga et al. 
1999-3  
8 men Longitudinal 7000 17 days Acclimatised Simulated 
hypobaric 
Passive SL: 44 
(24) 
ALT: 32 
(8) 
 
- - - - - - 
Data are mean (SD); RCT = randomised controlled trial, SL = sea-level, ALT = altitude 
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Supplementary Table 3. Individual study characteristics for studies evaluating fasted hunger 
Study Standardised 
mean 
difference  
Standard error Variance Lower 95% 
confidence 
interval 
Upper 95% 
confidence 
interval 
z-value p-value Sample 
size 
Weight 
Aeberli et al. 2013-1  -2.000 0.362 0.131 -2.709 -1.291 -5.528 0.000 22 5.66 
Aeberli et al. 2013-2  0.692 0.233 0.054 0.236 1.148 2.976 0.003 22 6.52 
Westerterp-Plantenga et al. 
1999-1  -1.172 0.450 0.202 -2.054 -0.290 -2.605 0.009 8 5.04 
Westerterp-Plantenga et al. 
1999-2 -2.146 0.629 0.396 -3.380 -0.912 -3.409 0.001 8 3.90 
Westerterp-Plantenga et al. 
1999-3 -3.406 0.903 0.816 -5.177 -1.636 -3.770 0.000 8 2.61 
Debevec et al. 2014a-1  0.149 0.297 0.088 -0.433 0.731 0.502 0.616 11 6.11 
Debevec et al. 2014a-2  0.117 0.296 0.088 -0.464 0.698 0.394 0.693 11 6.11 
Debevec et al. 2014a-3  -0.097 0.296 0.088 -0.678 0.483 -0.328 0.743 11 6.11 
Debevec et al. 2014a-4  -0.067 0.296 0.087 -0.646 0.513 -0.225 0.822 11 6.11 
Debevec et al. 2014b-1  0.061 0.347 0.120 -0.619 0.741 0.176 0.860 8 5.77 
Debevec et al. 2014b-2 0.221 0.351 0.123 -0.466 0.908 0.631 0.528 8 5.74 
Debevec et al. 2014b-3  0.859 0.468 0.219 -0.059 1.776 1.835 0.067 6 4.92 
Debevec et al. 2014b-4  -0.450 0.420 0.176 -1.273 0.373 -1.072 0.284 6 5.25 
Debevec et al. 2016-1  -0.191 0.298 0.089 -0.775 0.393 -0.641 0.521 11 6.10 
Debevec et al. 2016-2  -0.095 0.296 0.088 -0.675 0.485 -0.321 0.748 11 6.11 
Mean -0.347 0.212 0.045 -0.763 0.069 -1.637 0.102   
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Supplementary table 4. Individual study characteristics for studies evaluating postprandial hunger 
Study Standardised 
mean 
difference 
Standard error Variance Lower 95% 
confidence 
interval 
Upper 95% 
confidence 
interval 
z-value p-value Sample 
size 
Weight 
Aeberli et al. 2013-1 -0.234 0.191 0.036 0.608 0.140 1.224 0.221 22 12.96 
Aeberli et al. 2013-2 0.232 0.191 0.036 -0.142 0.606 1.214 0.225 22 12.97 
Westerterp-plantenga et al. 
1999-1 
-0.276 0.318 0.101 -0.900 0.348 -0.868 0.386 
8 4.97 
Westerterp-plantenga et al. 
1999-2 
-0.356 0.322 0.104 -0.987 0.275 -1.106 0.269 
8 4.85 
Westerterp-plantenga et al. 
1999-3 
-0.526 0.333 0.111 -1.179 0.127 -1.579 0.114 
8 4.54 
Bailey et al. 2015-1 0.099 0.256 0.065 -0.402 0.600 0.388 0.698 12 7.55 
Bailey et al. 2015-2 -0.100 0.256 0.065 -0.601 0.401 -0.392 0.695 12 7.55 
Wasse et al. 2012-1 -0.731 0.314 0.099 -1.347 -0.115 -2.324 0.020 10 5.08 
Wasse et al. 2012-2 -0.416 0.291 0.085 -0.987 0.154 -1.430 0.153 10 5.89 
Debevec et al. 2016-1 0.054 0.266 0.071 -0.469 0.576 0.201 0.841 11 6.97 
Debevec et al. 2016-2 -0.044 0.266 0.071 -0.566 0.478 -0.165 0.869 11 6.98 
Morishima & Goto 2016 -0.306 0.319 0.102 -0.932 0.320 -0.957 0.338 8 4.93 
Matu et al. 2017-1 0.112 0.256 0.065 -0.390 0.613 0.436 0.663 12 7.54 
Matu et al. 2017-2 -0.321 0.261 0.068 -0.834 0.191 -1.229 0.219 12 7.23 
Mean -0.146 0.072 0.005 -0.288 -0.005 -2.023 0.043   
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Supplementary table 5. Individual study characteristics for studies evaluating energy intake 
Study Standardised 
mean 
difference 
Standard error Variance Lower 95% 
confidence 
interval 
Upper 95% 
confidence 
interval 
z-value p-value Sample 
size 
Weight 
Aeberli et al. 2013-1  -0.763 0.240 0.058 -1.233 -0.293 -3.181 0.001 22 14.73 
Aeberli et al. 2013-2  -0.154 0.212 0.045 -0.570 0.262 -0.724 0.469 22 15.62 
Wasse et al. 2012-1  -0.888 0.370 0.137 -1.613 -0.164 -2.403 0.016 10 10.78 
Wasse et al. 2012-2  -1.205 0.411 0.169 -2.011 -0.399 -2.929 0.003 10 9.72 
Debevec et al. 2016-1 0.046 0.299 0.089 -0.539 0.631 0.154 0.878 11 12.85 
Debevec et al. 2016-2  -0.153 0.300 0.090 -0.741 0.436 -0.508 0.611 11 12.80 
Matu et al. 2017a-1 0.021 0.286 0.082 -0.540 0.581 0.072 0.943 12 13.25 
Matu et al. 2017a-2  -1.312 0.390 0.152 -2.076 -0.548 -3.365 0.001 12 10.26 
Mean -0.495 0.179 0.032 -0.845 -0.145 -2.770 0.006   
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Supplementary table 6. Individual study characteristics for studies evaluating postprandial acylated ghrelin concentrations 
Study Standardised 
mean 
difference 
Standard error Variance Lower 95% 
confidence 
interval 
Upper 95% 
confidence 
interval 
z-value p-value Sample 
size 
Weight 
Bailey et al. 2015-1 -0.108 0.071 0.005 -0.247 0.031 -1.518 0.129 12 15.04 
Bailey et al. 2015-2  -0.050 0.071 0.005 -0.189 0.089 -0.709 0.478 12 15.07 
Wasse et al. 2012-1 -0.237 0.079 0.006 -0.391 -0.083 -3.015 0.003 10 13.78 
Wasse et al. 2012-2  -0.137 0.078 0.006 -0.290 0.016 -1.760 0.078 10 13.90 
Morishima & Goto 2016  -0.169 0.087 0.008 -0.340 0.002 -1.940 0.052 8 12.46 
Matu et al. 2017a-1 -0.064 0.071 0.005 -0.203 0.074 -0.910 0.363 12 15.07 
Matu et al. 2017a-2 -0.367 0.073 0.005 -0.510 -0.224 -5.026 0.000 12 14.68 
Mean -0.160 0.043 0.002 -0.245 -0.075 -3.703 0.000   
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Supplementary table 7. Individual study characteristics for studies evaluating fasted total ghrelin concentrations 
Study Standardised 
mean 
difference 
Standard error Variance Lower 95% 
confidence 
interval 
Upper 95% 
confidence 
interval 
z-value p-value Sample 
size 
Weight 
Benso et al. 2007  0.295 0.373 0.139 -0.436 1.026 0.792 0.429 9 5.56 
Riedl et al. 2012-1  0.154 0.192 0.037 -0.222 0.530 0.805 0.421 33 7.72 
Riedl et al. 2012-2  0.644 0.227 0.052 0.198 1.090 2.830 0.005 28 7.30 
Riepl et al. 2012-4  -0.478 0.517 0.267 -1.491 0.536 -0.924 0.356 5 4.11 
Shukla et al. 2005-1  -0.798 0.252 0.063 -1.291 -0.305 -3.172 0.002 25 7.01 
Shukla et al. 2005-2  -1.015 0.270 0.073 -1.544 -0.486 -3.764 0.000 25 6.79 
Shukla et al. 2005-3  -0.469 0.231 0.053 -0.921 -0.016 -2.030 0.042 25 7.26 
Debevec et al. 2014b-1 -0.450 0.406 0.165 -1.246 0.347 -1.107 0.268 8 5.19 
Debevec et al. 2014b-2 -0.144 0.389 0.152 -0.907 0.619 -0.370 0.711 8 5.37 
Debevec et al. 2014b-3 0.248 0.454 0.206 -0.641 1.138 0.547 0.584 6 4.70 
Debevec et al. 2014b-4 0.489 0.473 0.224 -0.439 1.416 1.033 0.302 6 4.51 
Mekjavic et al. 2016  1.362 0.459 0.210 0.464 2.261 2.971 0.003 11 4.65 
Debevec et al. 2016-1  0.232 0.335 0.112 -0.424 0.888 0.693 0.488 11 6.00 
Debevec et al. 2016-2  0.366 0.341 0.116 -0.302 1.035 1.074 0.283 11 5.92 
Mean 0.003 0.170 0.029 -0.331 0.337 0.016 0.987   
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Supplementary table 8. Individual study characteristics for studies evaluating postprandial total ghrelin concentrations 
Study Standardised 
mean 
difference 
Standard error Variance Lower 95% 
confidence 
interval 
Upper 95% 
confidence 
interval 
z-value p-value Sample 
size 
Weight 
Riepl et al. 2012-4  -1.098 0.549 0.301 -2.174 -0.022 -2.001 0.045 5 10.65 
Debevec et al. 2014b-2 -0.106 0.344 0.118 -0.780 0.567 -0.309 0.757 8 21.35 
Debevec et al. 2014b-4  0.406 0.412 0.170 -0.401 1.214 0.987 0.324 6 16.65 
Debevec et al. 2016-1 0.065 0.293 0.086 -0.508 0.639 0.223 0.824 11 25.98 
Debevec et al. 2016-2  0.295 0.299 0.089 -0.290 0.881 0.989 0.323 11 25.98 
Mean 0.020 0.197 0.039 -0.367 0.407 0.101 0.920   
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Supplementary table 9. Individual study characteristics for studies evaluating fasted GLP-1 concentrations 
Study Standardised 
mean 
difference 
Standard error Variance Lower 95% 
confidence 
interval 
Upper 95% 
confidence 
interval 
z-value p-value Sample 
size 
Weight 
Bailey et al. 2004  0.370 0.135 0.018 0.105 0.636 2.736 0.006 7 11.49 
Debevec et al. 2014b-1  0.015 0.122 0.015 -0.225 0.255 0.124 0.901 8 12.48 
Debevec et al. 2014b-2  -0.095 0.123 0.015 -0.336 0.146 -0.775 0.439 8 12.46 
Debevec et al. 2014b-3  0.301 0.145 0.021 0.017 0.584 2.079 0.038 6 10.83 
Debevec et al. 2014b-4  -0.119 0.142 0.020 -0.398 0.159 -0.842 0.400 6 11.02 
Mekjavic et al. 2016  0.095 0.105 0.011 -0.110 0.300 0.910 0.363 11 13.93 
Debevec 2016-1  -0.223 0.106 0.011 -0.431 -0.016 -2.112 0.035 11 13.84 
Debevec 2016-2  -0.043 0.104 0.011 -0.248 0.161 -0.415 0.678 11 13.95 
Mean 0.028 0.070 0.005 -0.108 0.165 0.407 0.684   
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Supplementary table 10. Individual study characteristics for studies evaluating postprandial GLP-1 concentrations 
Study Standardised 
mean 
difference 
Standard error Variance Lower 95% 
confidence 
interval 
Upper 95% 
confidence 
interval 
z-value p-value Sample 
size 
Weight 
Bailey et al. 2015-1  -0.020 0.091 0.008 -0.199 0.158 -0.224 0.823 12 11.11 
Bailey et al. 2015-2  -0.019 0.091 0.008 -0.198 0.160 -0.209 0.835 12 11.11 
Debevec et al. 2014b-2 -0.078 0.112 0.013 -0.297 0.142 -0.694 0.488 8 8.63 
Debevec et al. 2014b-4 0.299 0.132 0.017 0.040 0.557 2.265 0.024 6 6.86 
Mekjavic et al. 2016  0.097 0.096 0.009 -0.090 0.284 1.014 0.310 11 10.54 
Debevec et al. 2016-1 0.114 0.096 0.009 -0.073 0.302 1.197 0.231 11 10.52 
Debevec et al. 2016-2  -0.227 0.097 0.009 -0.417 -0.038 -2.355 0.019 11 10.41 
Morishima & Goto 2016 0.112 0.112 0.013 -0.108 0.332 0.996 0.319 8 8.62 
Matu et al. 2017a-1  0.075 0.091 0.008 -0.105 0.254 0.816 0.414 12 11.09 
Matu et al. 2017a-2  0.027 0.091 0.008 -0.152 0.206 0.297 0.767 12 11.11 
Mean 0.029 0.040 0.002 -0.050 0.108 0.716 0.474   
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Supplementary table 11. Individual study characteristics for studies evaluating fasted leptin concentrations 
Study Standardised 
mean 
difference 
Standard error Variance Lower 95% 
confidence 
interval 
Upper 95% 
confidence 
interval 
z-value p-value Sample 
size 
Weight 
Zaccaria et al. 2004-1  -0.620 0.368 0.135 -1.340 0.101 -1.686 0.092 12 4.04 
Zaccaria et al. 2004-2  -0.848 0.393 0.154 -1.617 -0.079 -2.160 0.031 12 3.92 
Bailey et al. 2004  -0.482 0.466 0.217 -1.394 0.431 -1.034 0.301 7 3.58 
Benso et al. 2007  -0.842 0.452 0.205 -1.729 0.045 -1.861 0.063 9 3.64 
Castell et al. 2010-1 -0.533 0.211 0.044 -0.946 -0.121 -2.532 0.011 35 4.73 
Castell et al. 2010-2 -1.035 0.193 0.037 -1.414 -0.657 -5.361 0.000 56 4.79 
Castell et al. 2010-3 -0.510 0.170 0.029 -0.844 -0.176 -2.996 0.003 53 4.86 
Shukla et al. 2005-1  0.124 0.214 0.046 -0.295 0.542 0.578 0.563 30 4.71 
Shukla et al. 2005-2  0.930 0.255 0.065 0.430 1.429 3.648 0.000 30 4.55 
Shukla et al. 2005-3  0.848 0.248 0.062 0.361 1.334 3.414 0.001 30 4.58 
Smith et al. 2011-1  -0.131 0.370 0.137 -0.857 0.595 -0.354 0.723 10 4.03 
Smith et al. 2011-2  -0.026 0.369 0.136 -0.749 0.697 -0.071 0.943 10 4.04 
Smith et al. 2011-3  0.054 0.369 0.136 -0.669 0.777 0.146 0.884 10 4.04 
Tschop et al. 2000  0.659 0.288 0.083 0.095 1.223 2.292 0.022 20 4.41 
Vats et al. 2004-1  -1.335 0.507 0.257 -2.329 -0.341 -2.632 0.008 10 3.39 
Vats et al. 2004-2  -1.090 0.466 0.217 -2.002 -0.177 -2.340 0.019 10 3.58 
Vats et al. 2004-3  -1.162 0.477 0.228 -2.097 -0.226 -2.434 0.015 10 3.52 
Debevec et al. 2014b-1 0.515 0.439 0.193 -0.345 1.375 1.173 0.241 8 3.70 
Debevec et al. 2014b-2 -0.425 0.430 0.185 -1.268 0.419 -0.986 0.324 8 3.74 
Debevec et al. 2014b-3 0.795 0.546 0.298 -0.275 1.866 1.456 0.145 6 3.21 
Debevec et al. 2014b-4 -0.085 0.477 0.227 -1.020 0.850 -0.178 0.859 6 3.53 
Snyder et al. 2008  2.242 0.437 0.191 1.385 3.098 5.128 0.000 25 3.71 
Mekjavic et al. 2016  1.307 0.479 0.229 0.369 2.246 2.730 0.006 11 3.52 
Debevec et al. 2016-1  -0.354 0.362 0.131 -1.064 0.356 -0.977 0.329 11 4.07 
Debevec et al. 2016-2  -0.189 0.355 0.126 -0.884 0.506 -0.532 0.595 11 4.10 
Mean -0.086 0.159 0.025 -0.399 0.226 -0.542 0.588   
 
 
 
 
54 
 
Supplementary table 12. Individual study characteristics for studies evaluating fasted PYY concentrations 
Study Standardised 
mean 
difference 
Standard error Variance Lower 95% 
confidence 
interval 
Upper 95% 
confidence 
interval 
z-value p-value Sample 
size 
Weight 
Debevec et al. 2014b-1  -0.197 0.277 0.076 -0.739 0.345 -0.714 0.475 8 13.07 
Debevec et al. 2014b-2  0.218 0.277 0.077 -0.325 0.761 0.786 0.432 8 13.02 
Debevec et al. 2014b-3  -0.168 0.318 0.101 -0.792 0.456 -0.527 0.598 6 9.85 
Debevec et al. 2014b-4  -0.331 0.325 0.105 -0.967 0.306 -1.019 0.308 6 9.47 
Mekjavic et al. 2016  0.114 0.234 0.055 -0.345 0.573 0.487 0.626 11 18.20 
Debevec et al. 2016-1  0.083 0.234 0.055 -0.375 0.542 0.357 0.721 11 18.26 
Debevec et al. 2016-2  0.145 0.235 0.055 -0.315 0.606 0.620 0.535 11 18.13 
Mean 0.017 0.100 0.010 -0.179 0.213 0.170 0.865   
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Supplementary table 13. Individual study characteristics for studies evaluating postprandial PYY concentrations 
Study Standardised 
mean 
difference 
Standard error Variance Lower 95% 
confidence 
interval 
Upper 95% 
confidence 
interval 
z-value p-value Sample 
size 
Weight 
Bailey et al. 2015-1  -0.055 0.153 0.023 -0.354 0.245 -0.357 0.721 12 14.06 
Bailey et al. 2015-2  0.398 0.159 0.025 0.087 0.709 2.507 0.012 12 13.53 
Debevec et al. 2014b-2  0.103 0.188 0.035 -0.265 0.471 0.549 0.583 8 11.20 
Debevec et al. 2014b-4 -0.041 0.216 0.047 -0.465 0.383 -0.190 0.850 6 9.34 
Wasse et al. 2012-1  -0.285 0.171 0.029 -0.620 0.049 -1.670 0.095 10 12.50 
Wasse et al. 2012-2 -0.220 0.169 0.029 -0.552 0.112 -1.297 0.195 10 12.61 
Debevec et al. 2016-1  0.195 0.161 0.026 -0.121 0.510 1.208 0.227 11 13.32 
Debevec et al. 2016-2  0.022 0.160 0.025 -0.291 0.335 0.138 0.890 11 13.45 
Mean 0.019 0.081 0.006 -0.139 0.177 0.241 0.810   
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Supplementary table 14. Individual study characteristics for studies evaluating fasted insulin concentrations 
Study Standardised 
mean 
difference 
Standard error Variance Lower 95% 
confidence 
interval 
Upper 95% 
confidence 
interval 
z-value p-value Sample 
size 
Weight 
Zaccaria et al. 2004-1  0.204 0.311 0.097 -0.406 0.814 0.655 0.513 12 3.48 
Zaccaria et al. 2004-2  0.475 0.325 0.106 -0.162 1.113 1.462 0.144 12 3.40 
Bailey et al. 2004  -0.459 0.424 0.180 -1.290 0.373 -1.081 0.280 7 2.90 
Benso et al. 2007  0.333 0.366 0.134 -0.383 1.050 0.912 0.362 9 3.20 
Riedl et al. 2012-1  -0.154 0.187 0.035 -0.520 0.213 -0.823 0.411 33 4.08 
Riedl et al. 2012-2  0.196 0.204 0.041 -0.204 0.595 0.961 0.337 28 4.01 
Smith et al. 2011-1  -0.203 0.341 0.116 -0.871 0.466 -0.595 0.552 10 3.32 
Smith et al. 2011-2  0.180 0.340 0.116 -0.487 0.847 0.529 0.597 10 3.33 
Smith et al. 2011-3  0.553 0.363 0.131 -0.157 1.264 1.526 0.127 10 3.21 
Spliethoff et al. 2013-1 1.252 0.475 0.226 0.320 2.183 2.634 0.008 9 2.66 
Spliethoff et al. 2013-2  0.609 0.387 0.150 -0.151 1.368 1.571 0.116 9 3.09 
Vats et al. 2004-1  0.510 0.359 0.129 -0.193 1.214 1.421 0.155 10 3.23 
Vats et al. 2004-2  0.499 0.358 0.128 -0.203 1.201 1.393 0.164 10 3.24 
Vats et al. 2004-3 0.124 0.339 0.115 -0.541 0.788 0.365 0.715 10 3.33 
Young et al. 1989-1  0.431 0.456 0.208 -0.462 1.324 0.946 0.344 6 2.75 
Young et al. 1989-2  1.584 0.655 0.428 0.301 2.867 2.420 0.016 6 1.94 
Young et al. 1989-3  1.884 0.726 0.527 0.461 3.307 2.595 0.009 6 1.72 
Young et al. 1989-4 1.297 0.591 0.350 0.138 2.456 2.193 0.028 6 2.17 
Young et al. 1989-5 1.083 0.549 0.301 0.007 2.159 1.973 0.049 6 2.34 
Sawhney et al. 1991-1 3.565 0.748 0.559 2.099 5.030 4.768 0.000 15 1.65 
Sawhney et al. 1991-2 0.740 0.311 0.097 0.130 1.350 2.379 0.017 15 3.48 
Sawhney et al. 1991-3 2.224 0.514 0.264 1.217 3.231 4.329 0.000 15 2.49 
Sawhney et al. 1991-4 0.576 0.298 0.089 -0.008 1.159 1.934 0.053 15 3.55 
Sawhney et al. 1986  -0.270 0.344 0.118 -0.944 0.403 -0.787 0.431 10 3.31 
Larsen et al. 1997-1  2.138 0.684 0.468 0.797 3.479 3.124 0.002 8 1.84 
Larsen et al. 1997-2  -0.852 0.441 0.194 -1.716 0.012 -1.934 0.053 8 2.82 
Braun et al. 2001  0.965 0.373 0.139 0.234 1.697 2.587 0.010 12 3.16 
Debevec et al. 2014b-1 0.154 0.380 0.144 -0.591 0.898 0.405 0.686 8 3.12 
Debevec et al. 2014b-2 -0.974 0.458 0.210 -1.872 -0.075 -2.124 0.034 8 2.74 
Debevec et al. 2014b-3 0.983 0.531 0.282 -0.057 2.024 1.852 0.064 6 2.41 
Debevec et al. 2014b-4 -1.719 0.686 0.471 -3.064 -0.374 -2.505 0.012 6 1.84 
Mekjavic et al. 2016  0.004 0.322 0.104 -0.627 0.635 0.013 0.990 11 3.42 
Simpson et al. 2016-1 -0.336 0.331 0.109 -0.985 0.312 -1.016 0.310 11 3.38 
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Simpson et al. 2016-2 -0.145 0.324 0.105 -0.780 0.489 -0.449 0.653 11 3.41 
Mean 0.408 0.121 0.015 0.171 0.645 3.377 0.001   
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Supplementary table 15. Individual study characteristics for studies evaluating postprandial insulin concentrations 
Study Standardised 
mean 
difference 
Standard error Variance Lower 95% 
confidence 
interval 
Upper 95% 
confidence 
interval 
z-value p-value Sample 
size 
Weight 
Spliethoff et al. 2013-1  -0.104 0.324 0.105 -0.739 0.531 -0.321 0.748 9 8.25 
Spliethoff et al. 2013-2 0.223 0.327 0.107 -0.418 0.864 0.682 0.495 9 8.10 
Bailey et al. 2015-1 0.156 0.282 0.079 -0.396 0.708 0.555 0.579 12 10.93 
Bailey et al. 2015-2  0.049 0.280 0.078 -0.500 0.598 0.175 0.861 12 11.05 
Debevec et al. 2014b-2  -0.845 0.399 0.159 -1.627 -0.062 -2.116 0.034 8 5.44 
Debevec et al. 2014b-4 -0.609 0.431 0.186 -1.454 0.236 -1.413 0.158 6 4.67 
Mekjavic et al. 2016 0.240 0.297 0.088 -0.341 0.821 0.810 0.418 11 9.86 
Matu et al. 2017a-1  -0.056 0.280 0.078 -0.605 0.493 -0.201 0.841 12 11.05 
Matu et al. 2017a-2  0.082 0.280 0.079 -0.467 0.632 0.294 0.769 12 11.03 
Simpson et al. 2016-1 -0.343 0.301 0.090 -0.932 0.247 -1.139 0.255 11 9.58 
Simpson et al. 2016-2 0.136 0.294 0.086 -0.439 0.712 0.464 0.643 11 10.05 
Mean -0.035 0.093 0.009 -0.217 0.147 -0.376 0.707   
 
 
